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CHAPTER 1 
General Introduction 
The components of all plants, animals, and microorganisms are biosynthesized by 
enzyme reactions. The study of metabolism, a fundamental and vital procedure in living 
things, has provided us detailed understanding of the processes involved. A complex 
network of enzyme-catalyzed reactions, beginning with the photosynthetic reaction of 
carbon dioxide and water, is now evident that produces diverse compounds called primary 
metabolites (e.g., monomers such as amino acids, sugars, nucleotides, acetyl coenzyme A, 
and mevalonic acid, as well as polymers such as proteins, polysaccharides, lipids, and 
nucleic acids) [1]. This intricate network of vital biochemical reactions is referred to as 
primary metabolism. Several criteria distinguish secondary metabolites from primary 
metabolites. Secondary metabolites have restricted distributions that often are 
characteristic of individual genera, species, or strains. Moreover, they are formed from 
primary metabolites via specialized pathways. Unlike secondary metabolites, primary 
metabolites have a broad distribution and are common organic compounds in all living 
things. In particular, these latter metabolites are intimately involved in essential life 
processes. Although secondary metabolites probably are important to the organism that 
produces them, they are nonessential for life, and their roles are not apparent [2]. 
Secondary metabolites are biosynthesized from a small number of primary 
metabolites: acetyl coenzyme A (acetyl CoA), mevalonic acid, amino acids, sugars, and 
shikimic acid [3, 4]. In particular, acetyl CoA is an important intermediate of secondary 
metabolite biosynthesis because almost all other intermediates are directly or indirectly 
produced from it. The classification of secondary metabolites is based on biogenesis: 
terpenoids from isoprene units, polyketides from acetate units, metabolites from the 
shikimic acid pathway, alkaloids, and miscellaneous metabolites. 
Polyketide-derived compounds abound in both procaryotes and eucaryotes; for 
example, in actinomycetes and fungi [5]. Polyketides are secondary metabolites that 
represent a large group of secondary natural products. They also are one of the major 
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. 
sources of antibiotics, mycotoxins, plant growth regulators, pigments, enzyme inhibitor, 
and so on. Findings of a large number of previous investigations support the hypothesis 
that the mechanism of polyketide biosynthesis from short chain fatty acids, such as acetate, 
is closely related to that of fatty acid biosynthesis and is catalyzed by a multienzyme 
complex. In 1907 Collie [6] suggested that the [CHrCO] group could be made to yield a 
very large number of natural products by means of the simplest reactions. No biochemical 
support of his idea was provided until 1953 when Birch et al. [7] reported from the isotopic 
labeling patterns of several fungal metabolites that the biosynthesis of numerous secondary 
metabolites is correlated with repeating [CHrCO] units based on the acetate. Polyketide 
chain growth differs from fatty acid biosynthesis at several points (Fig. 1.1) [8]. In fatty 
acid biosynthesis, the addition of the next acetate unit (i.e., malonyl CoA) occurs together 
with fatty acid synthase (FAS) after reduction of the preceding unit is completed. 
polyketide biosynthesis, however, this addition may occur with polyketide synthase (PKS) 
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Fig. 1.1. Mechanisms of fatty acid polyketide forn1ation. 
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before the reduction, leading to the incorporation of double bonds and hydroxyl and 
carbonyl groups into the growing chain; formation of aromatic, ether, or lactone ring 
system; and retention of acetate-derived oxygen atoms in the metabolites [9-11]. Another 
difference is addition of such moieties as methyl and acetyl groups, terpene chains, amino 
acids, and/or sugar residues to the polyketide metabolites [5]. C-methylation, 
particular, occurs before the release of the completed polyketide from the PKS enzyme 
[12-15]. In general, polyketides have the components of between four and ten acetate 
units. A large number of tetra-, penta-, hepta-, and octaketides are known, whereas tri-, 
hexa-, nona-, and decaketides are less common [ 4, 5]. 
The genus Neocosmospora belongs to the Sphaeriales, family Hypocreaceae, and 
occurs as a mild parasite on a wide range of host plants in tropical areas [16, 17]. Its 
frequent occurrence on soil or rhizosphere suggests that it may be a widely distributed 
root-infecting fungus. Neocosmospora vasinfecta E. F. Smith is a pathogen which causes 
root- and fruit-rot, and seedling damping-off in the Malvaceae, Leguminosae, Piperaceae, 
Cucurbitaceae, etc., including pepper, groundnuts, soybean, beans, coconuts, Albizzia, 
Crotalaria spp., and others. Soybean, Glycine ma:x L., an important crop for food, feed, 
and industrial uses, suffers Neocosmospora stem rot by this fungus [18]. The primary 
~ymptom is reddish to dark brown discoloration of the pith and xylem with occasional 
chlorosis and defoliation of the lower leaves. This fungus also damages pea plants and 
cress seedlings by its excretion of the phytotoxins javanicin and fusarubin which also have 
antifungal activity [ 16]. 
Neovasinin (Fig. 1.2) was isolated by Nakajima et al. from the culture filtrate of the 
strain (NHL2298) of Neocosmospora vasinfecta E. F. Smith var. africana (von Arx) 
Cannon et Hawksworth (Fig. 1.3), obtained from soil in Johannesburg (Republic of South 
Africa) [19]. It is phytotoxic to soybean, a host plant of this fungus [20]. Its structure has 
been deduced by spectroscopic methods and from a key reaction [ 19]. Its absolute 
stereochemistry has been established by X-ray analysis and from a degradation reaction 
[20]. A metabolite related to neovasinin, neovasinone (Fig. 1.2), also has been isolated 
from the same fungus [21]. 
Neovasinin is a new type of fungal metabolite that has a unique bicyclic unit, 2H,5H-
3 
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Fig. 1.2. Structures of neovasinin and neovasinone. 
Fig. 1.3. Neocosmospora vasinfecta E. F. Smith, strain NHL2298 
grown on potato-dextrose-agar medium at 24 °C for 10 days. 
pyrano[ 4,3-b ]pyran-2-one, and that probably is biosynthesized from a hexaketide and five 
C1 units. There are a few reports on metabolites that have this bicyclic unit; 
chlamydosporol [22], isochlamydosporol [23], and multiforisin C [24], but no biosynthetic 
investigations of these metabolites have been made [25]. In this research therefore my 
intention was to clarify the biosynthetic pathway of neovasinin, in particular the formation 
of the bicyclic unit. 
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In chapter 2, the isolation and structure determination of neovasipyrones A and B, 
neovasifuranones A and B, and vasinfectins A and B are described. In chapter 3, the 
isolation and structure determination of neovasipyridones A-F are described. In chapter 
4, the incorporation of 
13
C-labeled precursors into neovasinin, neovasipyrones, and 
neovasifuranones is described. The incorporation of [S- 13C
2
H3]-L-methionine into 
neovasinin, neovasipyrones, and neovasifuranones, as well as the replacement culture and 
enzymatic conversion of neovasifuranone A aldehyde to neovasifuranone A also are 
reported. 
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CHAPTER2 
Isolation and Structure Determination of Neovasipyrones, 
Neovasifuranones, and Vasinfectins 
Introduction 
Neocosmospora vasinfecta E. F. Smith is a pathogen which causes root- and fruit-rot 
and seedling damping-off in various plants [1]. N. vasinfecta NHL2298 produces 
neovasinin (1) which is phytotoxic to soybean, a host plant of this fungus [2, 3]. 
Compound 1 is a new type of fungal metabolite that has a unique bicyclic unit, 2H,5H-
pyrano[ 4,3-b]pyran-2-one, and that probably is biosynthesized from a hexaketide and five 
C1 units. To explore its biosynthetic pathway, in particular the fonnation of the bicyclic 
unit, the isolation of the metabolites biogenetically related to neovasinin (1), produced by 
this fungus, was attempted. The isolation and structures of six new metabolites, named 
neovasipyrones A (2a) and B (2b ), neovasifuranones A (Sa) and B (Sb), and vasinfectins 
A (9a) and B (9b) are described in this chapter. 
Results and Discussion 
N. vasinfecta NHL2298 produced neovasipyrones (2), neovasifuranones (5), and 
vasinfectins (9) trace amounts on the conventional malt-peptone-sucrose medium, 
which had been used for production of neovasinin (1). Addition of L-methionine to this 
medium, according to the report on the biosynthesis of secondary metabolites in another 
fungus [ 4], stimulated a dramatic production of neovasipyrones (2), neovasifuranones (5), 
and vasinfectins (9) as well as 1. In this study I adopted this improved culture condition. 
Neovasipyrones A (2a) and B (2b) in the acidic ethyl acetate extract of N. vasinfecta 
culture filtrate were purified by silica gel partition, silica gel, and Sephadex LH-20 column 
chromatography, successively. The separation of 2a from 2b was achieved by preparative 
thin-layer chromatography (TLC) to afford 2a and 2b both as pure compounds in 
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respective yields of 72 and 31 mg/L. Neovasifuranones A (Sa) and B (Sb) in the neutral 
ethyl acetate extract were purified by silica gel and Sephadex LH-20 column 
chromatography, successively. The separation of Sa from Sb also was achieved by 
preparative TLC to afford Sa and Sb both in a pure state in respective yields of 3.0 and 1.9 
mg/L. Vasinfectins A (9a) and B (9b) in the neutral ethyl acetate extract were purified by 
silica gel column chromatography preparative TLC, successively. The separation of 
9a from 9b was achieved by reversed phase high performance liquid chromatography 
(HPLC) to afford 9a and 9b both as pure compounds in respective yields of 0.48 and 0.50 
mg/L. 
Neovasipyrones A and B. 
Neovasipyrone A (2a) had a molecular formula of C17H260 6 [high resolution fast 
atom bombardment mass spectrometry (HRFABMS) and 13C NMR data]. The 13C NMR 
spectrum of 2a (Table 2.1) showed 17 resonances, five of which were due to methyls, two 
9 
Table 2.1. NMR data (1H, 270.05 MHz and 13C, 67 .80 MHz) for 
neovasipyrones A (2a) and B (2b) in acetone-d6• 
-
2a 2b 
Position 
8c 8n 8c OH 
1 164.9 164.7 
2 100.6 100.7 
3 167.7 167.5 
4 110.4 110.7 
5 163.5 163.3 
6 75.5 75.2 
7 132.7 5.74 dq (1.1, 1.2) 134.7 5.69 dq (0.7, 1.3)" 
8 140.3 140.0 
9 80.8 3.66 dd (1.1, 5.8) 83.2 3.54 br. d (8.6) 
10 38.9 1.46 m 38.9 1.40m 
11 27.6 1.05 m 26.1 1.08 m 
1.35 m 1.71 m 
12 12.4 0.83 t (7.7) 11.9* 0.82 t (7.4) 
13 9.1 1.81 s 9.1 1.82 s 
14 58.8 4.80d(13.1) 58.7 4.85 d (13.4) 
4.88 d (13.1) 4.88 d (13.4) 
15 28.7 1.54 s 28.1 1.55 s 
16 13.8 1.43 d (1.2) 12.4* 1.39 d (1.3) 
17 14.7 0.81 d (6.9) 16.4 0.70 d (6.7) 
1H NMR data represent chemical shift, multiphcity (Jin Hz). 
* Assignments may be interchanged. 
to methylenes, three to methines, and seven to quaternary carbons from a distortionless 
enhancement by polarization transfer (DEPT) experiment [5], indicative of four hydroxyls 
in 2a. The five 
13C resonances (8c 100.6, 110.4, 163.5, 164.9, and 167.7), together with 
the ultraviolet (UV) absorption at 291 nm and the infrared (IR) absorption bands (3373, 
1663, and 1567 cm-1), indicated a trisubstituted 4-hydroxy-2H-pyran-2-one moiety in 2a 
[2, 6, 7]. Two 13C resonances (8c 132.7 and 140.3) were attributed to two olefinic carbons 
10 
in a trisubstituted double bond. The structure of 2a was unambiguously deduced from 
analysis of 1H-1H correlation spectroscopy (HJ-I-COSY) [8, 9], C,H-COSY [10, 11], long-
range C,H-COSY (COLOC) [10, 11], and nuclear Overhauser effect (NOE) difference 
spectral data. The COLOC spectrum of 2a was especially helpful in the assignment of the 
structure. The significant correlations in the COLOC spectrum are summarized in Fig. 
2.1. 
The structure of the side chain (C-6 to C-12) was deduced from H,H-COSY and 
COLOC data. The H,H-COSY data allowed the construction of a 1-hydroxy-2-
methylbutyl group. Additionally, the olefinic proton, 7-H (Ou 5.74), had the allylic 
correlations with both the hydroxymethine proton, 9-H (8ll 3.66), and the methyl protons, 
16-H3 (811 1.43), indicative of the attachment of a 1-hydroxy-2-methylbutyl group and•a 
methyl group (C-16) to the olefinic carbon, C-8, in the double bond. The stereochemistry 
around the double bond was assigned as E on the basis of NOE data. Irradiation of the 
signal of the olefinic proton, 7-H (On 5.74), caused NOE enhancement on the signal of the 
hydroxymethine, 9-H (Ou 3.66), but had no effect on the signal of the methyl protons, 16-
H3 (o11 1.43). The connection of C-6 and C-7 was deduced from COLOC data as follows. 
First, the attachment of the methyl group, C-15, to the hydroxy quaternary carbon, C-6, 
was quite obvious from 1H and 13C NMR data. The two carbons, C-6 and C-7, had 
correlations with the methyl protons, 15-H3, and in addition, C-6 had a correlation with the 
olefinic proton, 7-H. Thus the establishment of the structure of the side chain was 
.~OH ~~ \~14 
H3C 0,~ 
''-/ ~3 I OH OH 
\__ 1 5 (/,h\ 
o(c/K~.~ 
H~ CH3 
0 CH3 
CH3 
Fig. 2.1. Key long-range couplings detected in the COLOC 
experiment of neovasipyrone A (2a). 
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completed. The structure of the 4-hydroxy-2H-pyran-2-one portion was then established 
through the analysis of COLOC data. Three carbons, C-1, C-2, and C-3, were correlated 
with the methyl protons, 13-H3, and also three carbons, C-3, C-4, and C-5, were correlated 
with the hydroxymethyl protons, 14-H2• The carbon, C-5, had correlations with both the 
olefinic proton, 7-H, and the methyl protons, 15-H3. These correlations allowed the 
complete assignment of the 4-hydroxy-2H-pyran-2-one portion, and the entire structure 
therefore was established for 2a. 
Neovasipyrone B (2b) had a molecular formula of C17H260 6 (HRFABMS and 
13C 
NMR data) and the same structure as neovasipyrone A (2a) from their NMR data 
comparison (Table 2.1 ), that is, they are diastereomer of each other. Oxidation of 2a with 
Jones reagent [12] gave a 9-oxo derivative (3), which was identical with the derivative 
from 2b. This indicate that 2a and 2b are different only in the stereochemistry at C-9. To 
establish their stereochemistry by X-ray analysis, crystallization of 2a was attempted, but 
was unsuccessful. Fortunately, 2b was crystallized from acetone-benzene to afford plates 
containing one equivalent of benzene, and the crystals were adequate for X-ray analysis. 
The molecular structure of 2b is shown in Fig. 2.2. The relative configuration of 2b was 
found to be (6S*,9S*,10S*), and thus that of 2a was (6S*,9R*,10S*). Degradation of 2a 
was carried out to establish its absolute stereochemistry. The reaction of 2a with osmium 
tetroxide (Os04) and sodium metaperiodate (NaI04) [13], followed by treatment with 2,4-
Fig. 2.2. Perspective view of neovasipyrone B (2b) drawn by ORTEP-II [27]. 
12 
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Fig. 2.3. Structure of 2,4-dinitrophenylhydrazone of (S)-2-methyl-1-butanal (4). 
dinitrophenylhydrazine, afforded the 2,4-dinitrophenylhydrazone of 2-methyl-1-butanal ( 4, 
Fig. 2.3). Its optical rotation ( +24.7°) was identical with that of the synthetic 2,4-
dinitrophenylhydrazone of (S)-2-methyl-l-butanal (4, +23.3°) [3], indicative that the 
configuration of C-10 in 2a is S. Consequently, the absolute stereochemistry of 2a is 
(6S,9R,10S), and that of 2b is (6S,9S, lOS). 
Neovasifuranones A and B. 
Neovasifuranone A (Sa) had a molecular formula of C16H260 4 [high resolution 
electron ionization mass spectrometry (HREIMS) and 13C NMR data]. The 13C NMR 
spectrum of Sa (Table 2.2) showed 16 resonances, five of which were due to methyls, three 
to methylenes, three to methines, and five to quaternary carbons, indicative of two 
hydroxyls in Sa. The four 13C resonances (Oc 91.0, 114.1, 194.0, and 208.2), together with 
the UV absorption at 268 nm and the IR absorption bands (1688 and 1611 cm-1), indicated 
a tetrasubstituted 2,3-dihydrofuran-3-one portion in Sa [14-16]. Two 13C resonances (Oc 
124.4 and 146.0) were attributed to two olefinic carbons in a trisubstituted double bond. 
The structure of Sa was unambiguously deduced from analysis of H,H-COSY, C,H-COSY, 
COLOC, and NOE data in the same manner as in the structural elucidation of 
neovasipyrone A (2a). The significant correlations in the COLOC spectrum are 
summarized in Fig. 2.4. Acetylation of Sa afforded a diacetyl derivative (6), in the 1H 
NMR spectrum of which two proton resonances associated with a hydroxymethine and a 
hydroxymethyl were shifted downfield (from oil 3.68 to 4.92 and from OH 4.20 to 4.64 and 
4.66), indicative that the two carbons, C-7 and C-13, in Sa bear free hydroxyl groups. 
The structure of the side chain (C-5 to C-10) was deduced to be 3-hydroxy-2,4-
dimethyl- l-hexenyl from H,H-COSY and COLOC data. The stereochemistry of the 
13 
Table 2.2. NMR data (1"f-I, 270.05 MHz and 13C, 67 .80 MHz) for 
neovasifuranones A (Sa) in CD 30D and B (Sb) in CDC13 • 
Sa Sb 
Position 
Oc o,, Oc OH 
1 194.0 189.5 
2 114.1 111.9 
3 208.2 205.6 
4 91.0 88.5 
5 124.4 5.45 dq (1.0, 1.1) 123.7 5.44 dq (l.2, 1.0) 
6 146.0 143.5 
7 82.3 3.68 dd (1.0, 6.5) 82.1 3.66 br. d (7.7) 
8 39.5 1.49 m 37.5 1.50m 
9 28.1 1.08 m 24.4* l.10m 
1.38 m l.66m 
10 12.7 0.90 t (7.3) 11. li' 0.89 t (7.3) 
11 24.2 2.69 dq (14.6, 7.6) 22.5* 2.62 dq (13.9, 7.5) 
2.75 dq (14.6, 7.6) 2.67 dq (13.9, 7.5) 
12 11.6 1.25 t (7 .6) 10.61" 1.25 t (7 .5) 
13 53.2 4.20 s 53.4 4.31 s 
14 25.2 1.47 s 23.9 1.51 s 
15 14.8 1.70 d (1.1) 12.81" 1.73 d (1.0) 
16 15.2 0.84 d (6.7) 15.6 0.73 d (6.8) 
1H NMR data represent chemical shift, multiplicity (Jin Hz). 
*, i' Assignments may be interchanged. 
CH3 
CH3 
Fig. 2.4. Key long-range couplings detected in the COLOC 
experiment of neovasifuranone A (Sa). 
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double bond was assigned as E on the basis of NOE data. Irradiation of the signal of the 
olefinic proton, 5-H (on 5.45), caused NOE enhancement on the signal of the 
hydroxymethine, 7-H (o11 3.68), but had no effect on the signal of the methyl protons, 15-
H3 (on 1.70). A methyl, an ethyl, and a hydroxymethyl group in Sa were deduced from 1H 
NMR data. The substitution pattern around the 2,3-dihydrofuran-3-one moiety was 
established on the basis of COLOC data. The three carbons, C-1, C-2, and C-3, were 
correlated with the hydroxymethyl protons, 13-H2, and the two carbons, C-1 and C-2, were 
correlated with the methylene protons, ll-H2• The three carbons, C-3, C-4, and C-5, had 
correlations with the methyl protons, 14-H3, and furthermore, the carbon, C-4, had a 
correlation with the olefinic proton, 5-H. These correlations allowed the complete 
assignment of Sa, and the entire structure was established. 
Neovasifuranone B (Sb) had a molecular formula of C16H260 4 (HREIMS and 
13C 
NMR data) and the same structure as neovasifuranone A (Sa) from their NMR data 
comparison (Table 2.2), that is, they are diastereomer of each other. The compound Sa 
was treated with pivaloyl chloride and pyridine [17] and then oxidized with dimethyl 
sulfoxide (DMSO) and acetic anhydride (Ac20) [18] to afford 7-oxo derivative (7), which 
was identical with the derivative from Sb. This indicate that Sa and Sb are different only 
in the stereochemistry at C-7. The stereochemistries of C-7 and C-8 in neovasifuranones 
(S) were determined by chemical reactions. Acetylation of Sa with Ac20 and pyridine 
gave 6. The reaction of 6 with ruthenium trichloride (RuC13) and NaI04 [19], followed by 
treatment of the product with 2,4-dinitrophenylhydrazine, afforded the 2,4-
dinitrophenylhydrazone of 3-acetoxy-4-methyl-2-hexanone (Sa, Fig. 2.5). The same 
treatments of Sb gave 8b (Fig. 2.5). Similar reactions of neovasipyrones A (2a) and B 
~ I ~ 02N'(XN02 OAc 
~ ~/N~CH3 
02N'(XN02 OAc 
I N.. ;__ /'._ ~ ~/I '( 'CH3 
CH3 CH3 CH3 CH3 
Ba 8b 
Fig. 2.5. Structures of 2,4-dinitrophenylhydrazone of 3-acetoxy-4-methyl-2-hexanone 
(Sa and Sb). 
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(2b), whose absolute stereochemistries were established by X-ray analysis and chemical 
reactions, respectively gave the same products, 8a and 8b. The configurations of C-7 and 
C-8 in Sa therefore are (R,S), and in Sb are (S,S). The stereochemistry of C-4 has yet to be 
resolved. 
Vasinfectins A and B. 
The 13C NMR (Table 2.3) and HREIMS spectra of vasinfectin A (9a) gave the 
molecular formula C21H 280 4 (eight unsaturations). The 
13C NMR spectrum of 9a had 21 
resonances: six owing to methyl groups, two to methylenes, five to methines, and eight to 
quaternary carbons from its DEPT data. Acetylation of 9a afforded a monoacetyl 
derivative (10), in the 1H NMR spectrum of which proton resonance associated with~a 
hydroxymethine was shifted downfield (from Orr 3.77 to 4.99), indicative that the carbon, 
C-10, in 9a bear free hydroxyl group. The 1H and 13C NMR spectra (Table 2.3) of 9a 
indicate the presence of two carbonyl groups, three sp2 methines, and five sp2 quaternary 
carbons; therefore, 9a contains two rings in its structure. The structural fragments of 9a 
shown in Fig. 2.6 were deduced from H,H-COSY, C,H-COSY, COLOC experiments, and 
a consideration of chemical shift. The stereochemistry of the olefinic bond (C-8 and C-9) 
was confirmed by NOE data. Irradiation of the methine proton, 10-H (On 3.77), caused 
NOE enhancement of the olefinic proton signal, 8-H (Orr 5.56), and irradiation of the 8-H 
proton induced NOE enhancement of the 10-H signal. The geometry of this double bond 
0 
~ 
16 15 
CH3-CH2-11 
-AH, 
18 
0 
4 
__.t r /'...13 
It" '-110 I ""CH3 
CH3 CH3 
19 20 
~4 3a I a 
CH3 
17 
Fig. 2.6. Structural fragments of vasinfectin A (9a). 
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-Table 2.3. NMR data (1H, 270.05 MHz and 13C, 67.80 MHz) for 
vasinfectins A (9a) and B (9b) in CDC13• 
9a 9b 
Position 
Oc Ou Oc On 
2 90.8 90.7 
3 202.4 202.3 
3a 118.8 118.8 
4 123.1 8.07 d (1.8) 123.1 8.10 d (1.8) 
5 131.3 131.2 
6 137.9 8.11 dq (1.8, 0.9) 138.0 8.14 dq (1.8, 0.9) 
7 124.1 124.2 
7a 172.6 172.5 
8 122.6 5.56 dq (1.1, 1.1) 123.4 5.55 dq (l.2, 1.2) 
9 144.0 144.1 
10 80.7 3.77 br. d (6.1) 82.1 3.68 br. d (7.7) 
11 37.4 1.50m 37.4 1.51 m 
12 26.3 1.10 m 24.3 1.11 m 
1.34 m 1.66m 
13 11.6 0.88 t (7 .3) 11.1 0.88 t (7.3) 
14 198.9 199.0 
15 31.5 2.94 q (7.3) 31.5 2.97 q (7.3) 
16 8.4 1.19 t (7.3) 8.4 1.21 t (7.3) 
17 14.3 2.33 br. s 14.3 2.36 br. s 
18 24.0 1.59 s 24.0 1.62 s 
19 13.7 1.66 d (l.1) 12.9 1.68 d (1.2) 
20 13.6 0.82 d (6.8) 15.6 0.72 d (6.8) 
1H NMR data represent chemical shift, multiplicity (Jin Hz). 
therefore was established as the E configuration. The connections of these structural 
fragments were deduced from the long-range 13C-1H correlation detected in the COLOC 
spectrum (Fig. 2.7). The three carbon resonances, C-2, C-3, and C-8, were correlated with 
the 18-H3 signal, indicative that C-2 bound with C-3 and C-8. The connection of C-14 
with C-5 and C-15 was shown by correlation of the carbon resonance for C-14 with the 4-
17 
CH3 
18 
Fig. 2.7. Key long-range couplings detected in the COLOC 
experiment of vasinfectin A (9a). 
CH3 
H, 6-H, and 15-H2 signals. The C-3 signal was correlated with the 4-H signal, indicative 
of a bond between C-3 and C-3a. The unsaturation of 9a and chemical shifts of the 
aromatic carbon, C-7a (be 172.6), indicated a bond between C-7a and the oxygen atom on 
C-2. The chemical shifts of the signals produced by the benzofuranone ring carbons in the 
13C NMR spectrum of 9a, especially those of the furanone ring carbons (C-2, C-3, C-3a, 
and C-7a), are consistent with the shifts reported for other benzofuranone compounds 
[20-22]. Consequently, the planar structure for 9a was established. 
Vasinfectin B (9b) had the same molecular formula, C21H280 4 , as vasinfectin A (9a), 
and its specu·al features are very similar to those of 9a. All 1H and 13C NMR signals were 
assigned as shown in Table 2.3 by results of H,H-COSY and C,H-COSY experiments. 
The geometry of its double bond, E, was confirmed by NOE data. These findings 
suggested that 9b is a diastereomer of 9a. Oxidation of 9a with DMSO and Ac20 gave a 
10-oxo derivative (11), which was identical with the de1ivative from 9b. Thus 9b is a 
diastereomer of 9a differing only in its stereochemistry at C-10. The stereochemisuies of 
C-10 and C-11 in vasinfectins (9) were determined by the same method as used for 
neovasifuranones (5). Acetylation of 9a with Ac20 and pyridine gave 10. The reaction 
of 10 with RuC13 and NaI04, followed by treatment of the product with 2,4-
dinitrophenylhydrazine, afforded 8a (Fig. 2.5). The same treatments of 9b gave 8b. The 
configurations of C-10 and C-11 in 9a therefore are (R,S), and in 9b are (S,S). The 
stereochemistry of C-2 has yet to be resolved. However, the absolute stereochemistries of 
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neovasinin (1) and neovasipyrones (2) suggest that the stereochemistry of the remaining 
asymmetric carbon in neovasifuranones (5) and vasinfectins (9) would be S as shown in 
the figure. 
Neovasipyrones (2), neovasifuranones (5), and vasinfectins (9) have the same side 
chain, but they have different ring system; respectively, cx.-pyrone, 3(2H)-furanone, and 
3(2H)-benzofuranone. In addition, these metabolites were isolated from the same fungus, 
each as a mixture of two diastereomers with respect to the hydroxymethine carbon on the 
side chain. It is noteworthy that this fungus produces three types of biogenetically related 
diastereomers simultaneously, probably by the enzyme-catalyzed reactions [23, 24]. 
Preliminary leaf spot bioassay indicated that neovasifuranones (5) and vasinfectins 
(9) were phytotoxic to soybean, but neovasipyrones (2) were not. Neovasinin (1) caused 
necrosis at 2 µg per plant on soybean leaves; compounds 5 caused no symptom at 2 µg per 
plant, but caused necrosis at 5 µg per plant. Compounds 9 caused necrosis at 2 µg per 
plant, but the symptom size caused by 9 were fairly smaller than the size caused by 1 and 
s. 
Experimental Section 
General procedure. 
NMR spectra were recorded on a JEOL JNM GX-270 Ff NMR spectrometer or a 
JEOL JNM GX-400 FT NMR spectrometer. All NMR chemical shifts were referenced 
against the deuterated solvent used (CDCh oll 7.26, oc 77.0; Me2CO-d6, 011 2.00, oc 30.3; 
CD30D, 011 3.30, oc 49.8). Mass spectra were obtained with a JEOL DX-300 spectrometer 
or a JEOL AX-505 spectrometer. In FABMS, glycerol was used as matrix. In EIMS, the 
ionization voltage was 70 eV. IR spectra were measured with a JASCO FT/IR-7000 
spectrometer, and UV spectra with a Shimadzu UV-2200 UV-vis recording 
spectrophotometer. Optical rotations were determined with a Horiba SEPA-200 high 
sensitive polarimeter. Circular dichroism (CD) spectra were measured with a JASCO J-
720 spectrophotometer. Daisogel IR-60 was the silica gel used for the column 
chromatography. Preparative TLC was carried out on Merck Kieselgel 60 HF254 glass 
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plates (20 x 20 x 0.05 cm). 
Fungal material. 
Strain NHL2298 of Neocosmospora vasinfecta E. F. Smith var. africana (von Arx) 
Cannon et Hawksworth used in this study was a gift from Dr. Shun-ichi Udagawa 
(National Institute of Hygienic Sciences, Tokyo) in 1983 and was maintained on potato 
dextrose agar. 
Fermentation and extraction. 
The fungus was grown in 500-mL conical flasks (50) containing liquid medium (200 
mL/flask) made up of sucrose (50 g/L), peptone (3 g/L), the extract from 100 g/L on malt, 
L-methionine (0.3 g/L), and water, without shaking at 24°C for 21 days in the dark. The 
culture filtrate was acidified to pH 2.0 with HCl and extracted with EtOAc (3 x 7 L). The 
EtOAc extracts were dried over sodium sulfate (Na2S04), concentrated, and washed with 1 
M NaHC03 (2 x 0.5 vol.) to afford the neutral EtOAc-soluble (NE) fraction. The NaHC03 
washings were acidified to pH 2.0 with HCI and extracted with EtOAc (3 x 1 vol.) to 
afford the acidic EtOAc-soluble (AE) fraction. 
Isolation of neovasipyrones A (2a) and B (2b). 
The residue (5.7 g) from AE fraction was purified by silica gel partition column 
chromatography (300 g, impregnated with 180 mL of 0.1 M HC02H, 4.6 i.d. x 44 cm). 
Elution was performed with each 1.5 L (5 x 300 mL) of 10, 20, 30, 40, and 50% EtOAc in 
n-hexane saturated with 0.1 M HC02H. Fractions 15-21 were combined and 
concentrated. The residue (1.9 g) was subjected to silica gel column chromatography (180 
g, 3.2 i.d. x 44 cm). The column was developed with Me2CO-C6~-AcOH (40 : 60 : 0.5), 
and each 100 mL of eluate was collected as one fraction. The combined fractions (5-10, 
1.6 g) were then subjected to Sephadex LH-20 column chromatography (3.2 i.d. x 135 cm) 
using CHClrMeOH (1 : 1) as the solvent. Each 10 mL of eluate was collected as one 
fraction, and fractions 60-80, which contained both 2a and 2b, were combined. The 
separation of 2a from 2b was achieved by preparative TLC [Me2CO-CHC13-AcOH (25 : 
20 
.• 
75 : 1), quadruple development] to afford 720 mg of 2a (lower R1 band) and 310 mg of 2b 
(higher R1 band). 
Isolation of neovasifuranones A (Sa) and B (Sb). 
The combined NE fractions (5.9 g) from five cultivations (5 x 10 L of medium) were 
purified by silica gel column chromatography (140 g, 3.6 i.d. x 26 cm). The column was 
developed successively with 900 mL each of 2, 5, 10, 20, 30, 40, and 50% Me2CO in n-
hexane. The fraction (1.1 g), eluted with 30% Me2CO in n-hexane, was contained 
neovasifuranones (S) and subjected to Sephadex LH-20 column chromatography (3.2 i.d. x 
123 cm) using MeOH as the solvent. Each 10 mL of eluate was collected as one fraction, 
and fractions 60-69 were combined and concentrated. The residue (850 mg) was further 
purified by preparative TLC [Me2CO-CHC13 (1 : 3), triple development] to afford Sa (152 
mg, lower R1 band) and Sb (97 mg, higher R1 band). 
Isolation of vasinfectins A (9a) and B (9b ). 
The 10% fraction (270 mg), eluted from silica gel column chromatography of NE 
fractions, was subjected to preparative TLC [Me2CO-CHC13 (1 : 19)]. The residue (70 
mg) containing vasinfectins (9) was purified by reversed phase HPLC [COSMOSIL 5C18-
AR (10 i.d. x 250 mm), 75% aq. MeOH, 1.5 mL/min] to afford 9a (24 mg, R1 42.0 min) 
and 9b (25 mg, R1 38.7 min). 
Neovasipyrone A (2a). 
Oil. [cx]n20 -235.4° (c 1.0, EtOH). UV (EtOH) Amax nm (log £): 209 (4.29), 291 
(3.90). IR (film) Vmax cm-1: 3373, 2963, 1663, 1567, 1414, 1244, 988. 1H and 13C NMR 
spectral data: Table 2.1. FABMS m/z (rel. int.): 327 [M+Hf (39), 291 (35), 249 (26), 205 
(36), 191 (40), 179 (33), 109 (58), 43 (100); exact mass calcd for C17H270 6 327.1808, 
found 327.1791. 
Neovasipyrone B (2b). 
Oil. [cx]n20 -124.0° (c 1.0, EtOH). UV (EtOH) Amax nm (log E): 209 (4.25), 291 
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(3.87). IR (film) Vmax cm-1: 3373, 2967, 1680, 1565, 1419, 1245, 1010. 1H and 13C NMR 
spectral data: Table 2.1. FABMS m/z (rel. int.): 327 [M+Hf (30), 291 (12), 249 (16), 205 
(15), 179 (12), 109 (18), 106 (26), 74 (44), 42 (100); exact mass calcd for C17H270 6 
327.1808, found 327.1804. 
Crystal data for neovasipyrone B (2b). 
C17H 260 6 ·CJ-l6, M = 404.5, orthorhombic, space group ?212121, a = 24.773(4), b = 
r •3 11.525(2), c = 7.961(1) A, V = 2272.9(4) A (cell parameters by least squares from the 
setting angles of 24 reflections), µ(Cu Ka)= 6.5 cm-1, Z = 4, D, = 1.18 g cm-3, F(OOO) = 
872, T = 293 K. 
X-ray crystal structure analysis. 
Intensity data were measured on a Rigaku four-circle diffractometer using Ni-filtered 
Cu Ka radiation (A = 1.5418 A) and a rotating anode generator. A crystal of dimensions 
0.6 x 0.4 x 0.2 mm was used. The (1)-28 scan mode was employed, with background 
measurement at each end of the scan. Intensities of 1952 unique reflections were 
measured to 28max = 120° in the range 0 s h s 27, 0 s ks 12, 0 s ls 8, with (J.) scan width 
of 0.9° + 0.15° tan 8, a scan speed of 4° min-1, and background counting time of 5 sec. No 
significant change was observed in the intensities of the 3 standard reflections measured 
every 100 reflections. Intensity data were coITected only for Lorentz and polarization 
effects. The structure was determined by direct methods using SHELX 86 [25] and 
refined by block diagonal least squares [261 on F using atomic scattering factors from 
International Tables for X-ray Crystallography (1974). All H atoms for 2b molecule were 
located in the difference Fourier map, but those for the C6H6 molecule were invisible in the 
map. The oxygen and carbon atoms were refined anisotropically and the H atoms 
isotropically. Strongest reflection, 0 2 0, was omitted from the refinement. Weighting 
scheme used in the final stage of refinement was w = [a(F 0 )
2 + 0.02F0 + O.OOlF0
2r1• The 
residual electron densities in the final difference Fourier map ranged from -0.19 to 0.19 
eA-3• The final Rand Rw were 0.061 and 0.080, respectively, for 1728 unique reflections 
with F 0 > 2a(F 0 ). Atomic coordinates, temp. factors, and bond lengths and angles have 
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been deposited at the Cambridge Crystallographic Data Centre. 
Oxidation of neovasipyrones A (2a) and B (2b). 
A solution composed of chromium trioxide (Cr03, 500 mg), cone. H2S04 (0.5 mL), 
and H20 (1.5 mL) was prepared, and 50 µL was added to a stirred solution of 2a (36.0 mg) 
in 1.5 mL of Me2CO at 0°C. After 2 min, 20 µL of iso-PrOH was added to the reaction 
mixture. After 1 min, the reaction mixture was diluted with 30 mL of H20, and the 
solution was extracted with EtOAc (3 x 30 mL). The EtOAc solution was washed with 
brine, dried over Na2S04, filtered, and concentrated under reduced pressure. The residue 
was subjected to preparative TLC [Me2CO-CHClrAcOH (20 : 80: 1)] to afford 6.4 mg of 
compound 3 as an oil. [cx.] 0
22 -96° (c 1.0, EtOH). 1H NMR (270 MHz, CDC13): 8 0.85 
(3H, t, J = 7.0 Hz, H-12), 1.05 (3H, d, J = 7.0 Hz, H-17), 1.38 (lH, m, H-11), 1.59 (3H, s, 
H-15), 1.63 (lH, m, H-11), 1.76 (3H, br. s, H-16), 1.87 (3H, s, H-13), 3.11 (lH, ddq, J = 
7.0, 7.0, 7.0 Hz, H-10), 4.63 (lH, d, J = 13.5 Hz, H-14), 4.95 (lH, d, J = 13.5 Hz, H-14), 
6.73 (lH, br. S, H-7). EIMS m/z (rel. int.): 324 [Mr (3), 222 (8), 194 (42), 182 (51), 140 
(100), 57 (33). FABMS m/z (rel. int.): 325 [M+Hf (100), 307 (15), 291 (11), 249 (13), 
223 (19), 183 (25), 57 (37). Compound 2b (31.9 mg) was subjected to the same procedure 
as for 2a to afford 3 (5.4 mg), [cx]D22 -83° (c 1.0, EtOH). 
2,4-Dinitrophenylhydrazone of 2-methyl-1-butanal (4) from 2a. 
A solution of 2a (118 mg), Os04 (5 mg), and Nal04 (221 mg) in dioxane (2 mL), 
H20 (1.5 mL), and pyridine (0.1 mL) was stirred for 12 hr at room temperature. The 
reaction mixture was diluted with 20 mL of EtOAc, and the EtOAc solution was washed 
with brine (4 x 10 mL). A solution of 2,4-dinitrophenylhydrazine (308 mg) in EtOH (1.5 
mL) and cone. H2S04 (1 mL) was added to the EtOAc solution at 0°C, and the reaction 
mixture was stirred for 20 min. The reaction mixture was washed with brine (2 x 10 mL), 
dried over Na2S04, and concentrated to dryness. The residue was purified with silica gel 
flash column chromatography [Wakogel FC-40, EtOAc-n-hexane (1 : 9)] and preparative 
HPLC [Whatman Partisil 5-0DS-2 (8.0 i.d. x 150 mm), 1.0 mL/min, 85% aq. MeOH] to 
afford 5.5 mg of 4 as a yellow solid. The spectroscopic data were in accordance with 
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those reported previously. [cx]1/
2 +24.7° (c 0.3, CHC13). 
Neovasifuranone A (Sa). 
Oil. [cx]n22 -111.2° (c 0.4, EtOH). UV (EtOH) Amax nm (log £): 202 (3.91), 268 
(3.98). IR (film) Vmax cm-1: 3405, 2965, 1688, 1611, 1445, 1408, 1277, 1096, 1053, 1017. 
1H and 13C NMR spectral data: Table 2.2. EIMS m/z (rel. int.): 282 [Mr (5), 264 (13), 
246 (8), 235 (7), 225 (19), 207 (79), 189 (17), 151 (49), 121 (28), 111 (62), 109 (100), 57 
( 63); exact mass calcd for C16H260 4 282.1831, found 282.1837. 
Neovasifuranone B (Sb). 
22 • 
Oil. [cx]n -102.3° (c 0.4, EtOH). UV (EtOH) Amax nm (log £): 202 (3.93), 268 
(4.01). IR (film) Vmax cm-1: 3356, 2965, 1688, 1611, 1464, 1412, 1277, 1115, 1051, 1011. 
1H and 13C NMR spectral data: Table 2.2. EIMS m/z (rel. int.): 282 [Mr (9), 264 (12), 
246 (5), 235 (3), 225 (14), 207 (90), 189 (15), 151 (48), 121 (21), 111 (68), 109 (100), 57 
( 62); exact mass calcd for C16H260 4 282.1831, found 282.1831. 
Diacetyl neovasifuranone A (6). 
A solution of neovasifuranone A (Sa, 4.8 mg) in pyridine (0.1 mL) and Ac20 (50 µL) 
was allowed to stand for 12 hr at room temperature. The reaction mixture was added to 
H20 (2.5 mL), and the solution was stirred for 5 hr. The products were extracted with 
EtOAc (3 x 3 mL). The EtOAc solution was dried over Na2S04 and concentrated to 
dryness under reduced pressure. The residue was purified by preparative TLC 
[Me2CO-C6~ (1 : 4), double development] to afford 6 (5.1 mg) as an oil. UV (EtOH) 
Amax nm (log£): 202 (4.02), 266 (4.13). IR (film) Vmax cm-1: 2969, 1742, 1709, 1626, 1464, 
1412, 1373, 1236, 1022. 1H NMR (400 MHz, CDC13): 8 0.73 (3H, d, J = 6.6 Hz, H-16), 
0.82 (3H, t, J = 7.2 Hz, H-10), 1.04 (lH, m, H-9), 1.16 (3H, t, J = 7.5 Hz, H-12), 1.25 (lH, 
m, H-9), 1.41 (3H, s, H-14), 1.57 (lH, m, H-8), 1.67 (3H, d, J = 1.3 Hz, H-15), 1.96 (3H, s, 
Me of Ac), 2.00 (3H, s, Me of Ac), 2.59 (lH, dq, J = 14.7, 7.5 Hz, H-11), 2.62 (lH, dq, J = 
14.7, 7.5 Hz, H-11), 4.64 (lH, d, J = 12.2 Hz, H-13), 4.66 (lH, d, J = 12.2 Hz, H-13), 4.92 
(lH, br. d, J = 6.3 Hz, H-7), 5.35 (lH, dq, J = 1.3, 1.3 Hz, H-5). EIMS m/z (rel. int.): 366 
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[Mt (3), 306 (18), 249 (100), 217 (57), 207 (67), 179 (34), 151 (19), 138 (38), 109 (28). 
Oxidation of neovasifuranones A (Sa) and B (Sb). 
To a solution of Sa (20.5 mg) in pyridine (10 µL) and CH2Cl2 (0.5 mL), pivaloyl 
chloride (25 µL) was added, and the solution was stirred for 8 hr at 20°C. The reaction 
mixture was diluted with H20 (1 mL), stirred for 1 hr, and then diluted with EtOAc (20 
mL). The solution was washed with 1 M NaHC03 (2 x 10 mL) and brine (2 x 10 mL), 
dried over Na2S04, and concentrated to dryness under reduced pressure. A solution of the 
residue (26.7 mg) in dry DMSO (0.3 mL) and Ac20 (0.2 mL) was stirred for 18 hr at 20°C. 
EtOH (1.5 mL) was added to the reaction mixture, and the solution was stirred for 1 hr. 
The reaction mixture was diluted with H20 (10 mL), and the solution was extracted with 
EtOAc (4 x 10 mL). The EtOAc solution was washed with brine (2 x 15 mL), dried over 
Na2S04, and concentrated to dryness under reduced pressure. The residue was purified by 
preparative HPLC [COSMOSIL 5C18-AR (10 i.d. x 250 mm), 1.0 mL/min, 90% aq. 
MeOH] to afford compound 7 (6.4 mg) as an oil. [a]0
22 -40.3° (c 0.3, EtOH). UV 
(EtOH) Amax nm (log E): 235 (4.01), 266 (3.97). IR (film) Vmax cm-1: 2969, 1730, 1676, 
1626, 1462, 1406, 1281, 1204, 1150, 1051. 1H NMR (270MHz, CDCl3): o0.80 (3H, t,J 
= 7.4 Hz, H-10), 1.05 (3H, d, J = 6.8 Hz, H-16), 1.16 (9H, s, Me of pivaloyl), 1.25 (3H, t, J 
= 7.6 Hz, H-12), 1.35 (lH, m, H-9), 1.57 (3H, s, H-14), 1.62 (lH, m, H-9), 1.96 (3H, d, J = 
1.3 Hz, H-15), 2.72 (2H, q, J = 7.6 Hz, H-11), 3.08 (lH, ddq, J = 6.8, 6.8, 6.8 Hz, H-8), 
4.74 (2H, s, H-13), 6.44 (lH, dq, J = 0.5, 1.3 Hz, H-5). Chemical ionization mass 
spectrometry (CIMS) m/z (rel. int.): 365 [M+Hf (37), 263 (100). Compound Sb (19.8 
mg) was subjected to the same procedure as for Sa to afford 7 (3.2 mg), [a]0
22 -39.7° (c 
0.3, EtOH). 
Vasinfectin A (9a). 
Oil. [a]o20 -53° (c 0.5, EtOH). UV (EtOH) Amax nm (log c:): 202 (4.04), 243 (4.55), 
274 (3.97), 329 (3.54). IR (film) Ymax cm-1: 3434, 1725, 1686, 1607, 1163. 1H and 13C 
NMR spectral data: Table 2.3. EIMS m/z (rel. int.): 344 [Mt (7), 326 (13), 287 (100), 258 
(43), 231 (21), 191 (43), 161(12),57 (19); exact mass calcd for C21 H2804 344.1988, found 
25 
344.1983. 
Vasinf ectin B (9b ). 
Oil. [a]0
20 -41° (c 0.5, EtOH). UV (EtOH) Amax nm (log£): 202 (4.05), 243 (4.56), 
274 (3.97), 329 (3.54). IR (film) Vmax cm-1: 3499, 1726, 1686, 1607, 1163. 1H and 13C 
NMR spectral data: Table 2.3. EIMS m/z (rel. int.): 344 [Mr (5), 326 (10), 287 (100), 258 
(34), 231 (15), 191 (34), 161 (10), 57 (15); exact mass calcd for C21H280 4 344.1988, found 
344.1992. 
Monoacetyl vasinfectin A (10). 
A solution of vasinfectin A (9a, 11.2 mg) in pyridine (0.2 mL) and Ac20 (0.1 mE) 
was stirred for 6 hr at room temperature. The reaction mixture was added to H 20 (5 mL), 
and the solution was extracted with EtOAc (4 x 5 mL). The EtOAc solution was 
concentrated to dryness under reduced pressure. The residue was purified by preparative 
HPLC [COSMOSIL 5C18-AR (10 i.d. x 250 mm), 2.0 mL/min, 80% aq. MeOH] to afford 
10 (10.5 mg) as an oil. UV (EtOH) Amax nm (log £): 202 (4.02), 243 (4.57), 274 (3.95), 
329 (3.56). IR (film) Vmax cm-1: 1730, 1688, 1607, 1238. 1H NMR (270 MHz, CDC13): 8 
0.79 (3H, d, J = 6.7 Hz, H-20), 0.89 (3H, t, J = 7.3 Hz, H-13), 1.12 (lH, m, H-12), 1.22 
(3H,t,1=7.3Hz,H-16), 1.32(1H,m,H-12), 1.59(3H,s,H-18), 1.64(1H,m,H-11), 1.73 
(3H, d, J = 1.2 Hz, H-19), 2.06 (3H, s, Me of Ac), 2.36 (3H, br. s, H-17), 2.97 (2H, q, J = 
7.3 Hz, H-15), 4.99 (lH, br. d, J = 5.9 Hz, H-10), 5.51 (lH, dq, J = 1.2, 1.2 Hz, H-8), 8.10 
(lH, d, J = 1.8 Hz, H-4), 8.14 (lH, dq, J = 1.8, 0.9 Hz, H-6). EIMS m/z (rel. int.): 386 
[Mr (4), 326 (13), 300 (11), 287 (51), 258 (75), 218 (100), 191 (26), 161 (15), 127 (12), 
57 (17). 
Oxidation of vasinfectins A (9a) and B (9b). 
A solution of 9a (19.6 mg) in dry DMSO (0.3 mL) and Ac20 (0.2 mL) was stirred for 
18 hr at 20°C. EtOH (1.5 mL) was added to the reaction mixture, and the solution was 
stirred for 1 hr. The reaction mixture was added to H20 (10 mL), and the solution was 
extracted with EtOAc (4 x 10 mL). The EtOAc solution was washed with brine (2 x 15 
26 
mL), dried over Na2S04, and concentrated to dryness under reduced pressure. The residue 
was purified by preparative TLC [Me2CO-n-hexane (1 : 9), triple development] to afford 
compound 11 (9.8 mg) as an oil. CD (EtOH) Acxi nm (L\E): 342 (+6.6), 311 (-3.5), 245 
(-21.3). UV (EtOH) Amax nm (log E): 201 (3.94), 245 (4.63), 276 (3.91), 330 (3.56). IR 
(film) Ymax cm-1: 1728, 1684, 1607, 1161. 1H NMR (270 MHz, CDC13): o 0.80 (3H, t, J = 
7.4 Hz, H-13), 1.07 (3H, d, J = 6.8 Hz, H-20), 1.22 (3H, t, J = 7.3 Hz, H-16), 1.34 (lH, m, 
H-12), 1.63 (lH, m, H-12), 1.69 (3H, s, H-18), 2.01 (3H, hr. d, J = 1.3 Hz, H-19), 2.39 
(3H, br. s, H-17), 2.97 (2H, q, J = 7.3 Hz, H-15), 3.09 (lH, ddq, J = 6.8, 6.8, 6.8 Hz, H-
11), 6.53 (IH, q, J = 1.3 Hz, H-8), 8.12 (lH, d, J = 1.8 Hz, H-4), 8.17 (lH, dq, J = 1.8, 0.9 
Hz, H-6). EIMS m/z (rel. int.): 342 [Mf (45), 313 (67), 285 (34), 258 (54), 229 (91), 191 
(19), 152 (100), 123 (86), 57 (59). Compound 9b (20.2 mg) was subjected to the same 
procedure as for 9a to afford 11 (10.7 mg), CD (EtOH) Acxi nm (L\E): 342 (+6.6), 312 
(-3.6), 245 (-20.5). 
2,4-Dinitrophenylhydrazone of 3-acetoxy-4-methyl-2-hexanone (8a) from 2a. 
A solution of 2a (52.0 mg) in pyridine (0.2 mL), Ac20 (0.1 mL), and CH2Cl2 (0.4 
mL) was stirred for 22 hr at room temperature. H20 (10 mL) was added to the reaction 
mixture, and the solution was stirred for 1 hr. The reaction mixture was extracted with 
EtOAc (4 x 10 mL). The EtOAc solution was washed with brine ( 2 x 25 mL), dried over 
Na2S04, and concentrated to dryness under reduced pressure. A solution of the residue 
(71.0 mg), RuCh (5 mg), and NaI04 (130 mg) in CC~ (1 mL), CH3CN (1 mL), and H20 
(1.5 mL) was stirred vigorously for 1 hr at room temperature. The reaction mixture was 
added to EtOAc (20 mL), and the solution was washed with brine (4 x 10 mL). A solution 
of 2,4-dinitrophenylhydrazine (160 mg) in EtOH (1 mL) and cone. H2S04 (0.5 mL) was 
added to the EtOAc solution, and the solution was stirred for 40 min at room temperature. 
The reaction mixture was washed with brine (3 x 10 mL), dried over Na2S04, and 
concentrated to dryness under reduced pressure. The residue was purified by preparative 
TLC [Me2CO-n-hexane (1 : 19), quintuple development] to afford 8a (28.5 mg) as a 
yellow oil. [a]0
20 +24.9° (c 0.3, EtOH). IR (film) Vmax cm-1: 1744, 1618, 1595, 1518, 
1339, 1235. 1H NMR (270 MHz, CDC13): o 0.95 (3H, t, J = 7.3 Hz), 0.99 (3H, d, J = 6.6 
27 
Hz), 1.22 (lH, m), 1.43 (lH, m), 1.91 (lH, m), 2.04 (3H, s), 2.14 (3H, s), 5.26 (lH, d, J = 
7.0 Hz), 7.95 (lH, d, J = 9.5 Hz), 8.33 (lH, ddd, J = 9.5, 2.6, 0.5 Hz), 9.13 (lH, d, J = 2.6 
Hz), 11.05 (lH, br. s). EIMS m/z (rel. int.): 352 [Mr (67), 292 (45), 263 (91), 253 (56), 
207 (45), 191 (37), 59 (100). 
2,4-Dinitrophenylhydrazone of 3-acetoxy-4-methyl-2-hexanone (8b) from 2b. 
Compound 2b (52.0 mg) was subjected to the same procedure as for 2a to afford 8b 
(22.4 mg) as a yellow oil. [cx]1/
0 +14.0° (c 0.3, EtOH). IR (film) Ymax cm-1: 1742, 1618, 
1595, 1518, 1339, 1233. 1H NMR (270 MHz, CDC13): 8 0.90 (3H, d, J = 6.8 Hz), 0.95 
(3H, t, J = 7.3 Hz), 1.24 (lH, m), 1.59 (lH, m), 1.91 (lH, m), 2.04 (3H, s), 2.12 (3H, s), 
5.19 (lH, d, J = 8.2 Hz), 7.96 (lH, d, J = 9.5 Hz), 8.32 (lH, ddd, J = 9.5, 2.6, 0.5 Hz), 9. 
(lH, d, J = 2.6 Hz), 11.03 (lH, br. s). EIMS m/z (rel. int.): 352 [Mr (36), 292 (22), 263 
(43), 253 (30), 207 (25), 191 (20), 59 (100). 
Compound 8a from Sa and 8b from Sb. 
A solution of Sa (52.3 mg) in pyridine (0.2 mL), Ac20 (0.1 mL), and CH2Cl2 (0.4 
mL) was stirred for 22 hr at room temperature. H20 (5 mL) was added to the reaction 
mixture, and the solution was stirred for 1 hr. The reaction mixture was extracted with 
EtOAc (4 x 5 mL). The EtOAc solution was washed with brine (2 x 10 mL), dried over 
Na2S04, and concentrated to dryness under reduced pressure. A solution of the residue 
(64.0 mg), RuC13 (2 mg), and NaI04 (160 mg) in CC14 (0.5 mL), CH3CN (0.5 mL), and 
H20 (0.75 mL) was stirred vigorously for 12 hr at 28°C. The reaction mixture was added 
to EtOAc (10 mL), and the solution was washed with 1 M NaHC03 (2 x 5 mL) and brine 
(2 x 5 mL). A solution of 2,4-dinitrophenylhydrazine (180 mg) in EtOH (1 mL) and cone. 
H2S04 (0.2 mL) was added to the EtOAc solution, and the solution was stirred for 40 min 
at 28°C. The reaction mixture was washed with brine (3 x 10 mL), dried over Na2S04, and 
concentrated to dryness under reduced pressure. The residue was purified by preparative 
TLC [Me2CO-n-hexane (1 : 19), quintuple development] to afford 8a (33.1 mg), [cx]0
20 
+26.2° (c 0.3, EtOH). Compound Sb (54.8 mg) was subjected to the same procedure as 
for Sa to afford 8b (30.6 mg), [cx]o20 +14.8° (c 0.3, EtOH). 
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Compound Sa from 9a and Sb from 9b. 
A solution of 9a (21.0 mg) in pyridine (0.2 mL), Ac20 (0.1 mL), and CH2Cl2 (0.4 
mL) was stirred for 20 hr at room temperature. H 20 (5 mL) was added to the reaction 
mixture, and the solution was stirred for 1 hr. The reaction mixture was extracted with 
EtOAc (4 x 5 mL). The EtOAc solution was washed with brine (2 x 10 mL), dried over 
Na2S04, and concentrated to dryness under reduced pressure. A solution of the residue 
(23.8 mg), RuC13 (2 mg), and NaI04 (55 mg) in CC~ (0.5 mL), CH3CN (0.5 mL), and H 20 
(0.75 mL) was stirred vigorously for 12 hr at 28°C. The reaction mixture was added to 
EtOAc (10 mL), and the solution was washed with 1 M NaHC03 (2 x 5 mL) and brine (2 x 
5 mL). A solution of 2,4-dinitrophenylhydrazine (60 mg) in EtOH (1 mL) and cone. 
H 2S04 (0.2 mL) was added to the EtOAc solution, and the solution was stirred for 40 min 
at 28°C. The reaction mixture was washed with brine (3 x 10 mL), dried over Na2S04, and 
concentrated to dryness under reduced pressure. The residue was purified by preparative 
TLC [Me2CO-n-hexane (1 : 19), quintuple development] to afford Sa (7 .9 mg), [a]0
20 
+26.2° (c 0.3, EtOH). Compound 9b (21.3 mg) was subjected to the same procedure as 
for 9a to afford Sb (5.7 mg), [a]0
20 +16.0° (c 0.3, EtOH). 
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CHAPTER3 
Isolation and Structure Determination of Neovasipyridones 
Introduction 
In previous chapter, the structures of neovasipyrones A (2a) and B (2b ), 
neovasifuranones A (3a) and B (3b), and vasinfectins A and B are shown. These 
metabolites have the same side chain and were isolated from the culture filtrate of 
Neocosmospora vasinfecta NHL2298. To obtain other metabolites related to neovasinin 
(1) [1, 2], isolation of the metabolites from the mycelia was then attempted. The isolation 
and structures of six new metabolites, named neovasipyridones A (4a), B (4b), C (4c), D 
(4d), E (4e), andF (4f) are described in this chapter. 
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Results and Discussion 
Neovasipyridones A (4a), B (4b), C (4c), D (4d), E (4e), andF (4f) were isolated as 
oils with respective yields of 36, 23, 18, 35, 7.9, and 4.4 µg/g from air-dried mycelia of the 
fungus N. vasinfecta NHL2298 grown on a malt extract medium supplemented with 
peptone and L-methionine [3]. 
Table 3.1. 13C NMR data for neovasipyridones A-E (4a-e) in CDC13 • 
c 4a* 4b* 4c* 4d* 4et 
-
2 76.7 76.1 76.3 76.5 76.7 
3 71.1 70.9 71.0 70.9 70.8 
4 191.7 191.6 191.7 191.7 191.7 
5 104.9 104.8 104.8 104.9 104.8 
6 158.8 158.7 158.1 158.1 157.8 
7 127.6 127.7 127.5 127.7 127.7 
8 140.1 140.0 140.1 140.1 139.9 
9 34.0 34.0 34.0 34.0 34.0 
10 30.1 30.1 30.1 30.0 30.1 
11 11.8 11.8 11.8 11.8 11.9 
12 13.1 13.0 13.l 12.9 13.1 
13 20.6 20.6 20.6 20.7 20.7 
14 28.8 28.6 28.9 28.6 28.5 
15 197.6 197.6 197.6 197.5 197.7 
16 34.9 34.8 34.9 34.8 34.9 
17 8.5 8.6 8.5 8.5 8.6 
18 61.2 53.6 62.7 56.0 50.1 
19 33.7 37.6 27.2 35.3 14.3 
20 26.4 25.7 19.8 136.5 
21 10.8 22.0 20.1 129.0 
22 16.8 22.5 128.6 
23 127.3 
24 128.6 
25 129.0 
* 67.8 MHz, t 100 MHz. 
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The 13C NMR data (Table 3.1) and HRFAB mass spectrum of neovasipyridone A 
(4a) showed its molecular formula to be C21 H35N03 (five unsaturations). The 
13C NMR 
spectrum of 4a showed 21 resonances, seven of which were due to methyls, four to 
methylenes, five to methines, and five to quaternary carbons from a DEPT experiment [4], 
indicative that one of the protons in the molecule is bound to oxygen or nitrogen. The 2,3-
dihydro-4-pyridinone portion in 4a was indicated by two IR absorption bands at 1647 and 
1580 cm-1, three 13C resonances at Oc 191.7, 158.8, and 104.9, and a UV absorption at 322 
nm [5, 6]. Two 13C resonances at Oc 127.6 and 140.1 were attributed to two olefinic 
carbons of a trisubstituted double bond. One 13C resonance of Oc 197 .6 was characteristic 
of a ketonic carbonyl carbon conjugated to a double bond. The structure of 4a was 
unambiguously deduced from analysis of H,H-COSY [7, 8], C,H-COSY [9, 10], COLOC 
[9, 10], and NOE data. The significant correlations in the COLOC spectrum are 
summarized in Fig. 3.2. 
The partial structure A (Fig. 3.1) was deduced from H,H-COSY and COLOC data. 
The structure of the side chain (C-7 to C-11 ), deduced to be l ,3-dimethyl-1-pentenyl from 
H,H-COSY, was confirmed by COLOC data. The bonds between C-2 and C-7, and 
between C-2 and C-3, were deduced from COLOC data. The ally lie methyl carbon, C-12, 
was correlated with the methine proton, 2-H, indicative of the attachment of a 1,3-
dimethyl-1-pentenyl group to the methine carbon, C-2. Furthermore, the oxygen-bearing 
quaternary carbon, C-3, was correlated both with the methine proton, 2-H, and the methyl 
protons, 14-H3, and the methyl carbon, C-14, was in turn correlated with the methine 
proton, 2-H. These correlations indicated that the methyl carbon, C-14, is bound to the 
oxygen-bearing quaternary carbon, C-3, which is attached to the methine carbon, C-2. 
0 
11 0 
CH3 L17 
~21 !r ~H3 ~H3 15 CH3 CH3 CH3 22 ......... N 
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Fig. 3.1. Structural fragments of neovasipyridone A ( 4a). 
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Fig. 3.2. Key long-range couplings detected in the COLOC 
experiment of neovasipyridone A (4a). 
The stereochemistry of the double bond is E based on the NOE data. Irradiation of the 
methine proton, 2-H (on 3.82), caused NOE enhancement of the signal of the olefinic 
proton, 8-H (811 5.12), and irradiation of the olefinic proton, 8-H, induced NOE 
enhancement of the signal of the methine proton, 2-H. The partial structure A therefore 
was established. The partial structure B (Fig. 3.1) also was deduced from H,H-COSY and 
COLOC data. An ethyl group (C-16 and C-17) was indicated by the 1H NMR (Table 3.2) 
and H,H-COSY data. Attachment of the ethyl group to a ketonic carbonyl carbon, C-15, 
was deduced from the COLOC correlation of the carbonyl carbon, C-15, to the methyl 
protons, 17-H3, thus giving the partial structure B. The partial structure C (Fig. 3.1) was 
shown to be 2-methylbutyl from the 1 H NMR and H,H-COSY data. The partial structure 
D (Fig. 3.1) was deduced from the IR, UV, and 13C NMR data as described above. 
These four partial structures A-D were combined on the basis of COLOC data and a 
consideration of chemical shift. The carbonyl carbon, C-4, in partial structure D had 
COLOC correlations with the methyl protons, 14-H3, and with the methine proton, 2-H, 
both in partial structure A, indicative of a bond between C-3 and C-4. The COLOC 
correlation of the olefinic carbon, C-6, in partial structure D to the methine proton, 2-H, in 
partial structure A and the chemical shift of the methine carbon, C-2 (8c 76.7), were in 
agreement with there being a bond between C-2 and the nitrogen atom. The finished 
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Table 3.2. 
1
H NMR data (270.05 MHz) for neovasipyridones A-F (4a-f) in CDCh. 
H 4a 4b 4c 4d 4e 4f 
2 3.82 s 3.80s 3.80s 3.78 s 3.81 s 3.85 s 
6 8.21 s 8.25 s 8.20s 8.23 s 8.29 s 8.26 s 
8 5.12 dq (9.5, 0.9) 5.12 dq (10.8, 1.2) 5.13 dq (9.5, 1.0) 5 .14 dq (9. 7, 1.1) 5.12 dq (10.3, 1.1) 5.16 br. d (8.6) 
9 2.28m 2.25m 2.28m 2.23m 2.28m 2.20m 
10 1.10-1.40 m 1.10-1.42 m 1.07-1.40 m 1.08-1.42 m 1.10-1.40 m 1.10-1.40 m 
11 0.83 t (7.6) 0.82 t (7.5) 0.81 t (7.5) 0.82 t (7.6) 0.83 t (7.0) 0.83 t (7.6) 
12 1.43 d (0.9) 1.41 d (1.2) 1.41 d (1.0) l.39d(l.1) 1.44 d (1.1) 1.43 br. s 
13 0.93 d (6.8) 0.91 d (6.8) 0.91 d (6.8) 0.95 d (6.5) 0.92 d (6.5) 0.92 d (6.3) 
14 1.38 s 1.34 s 1.37 s 1.15 s 1.36 s 1.36 s 
w 16 2.86dq (17.1, 7.2) 2.84 dq (16.5, 7.5) 2.84 dq (17.0, 7.0) 2.78 dq (17 .2, 7 .6) 2.84 dq (17.3, 7.6) 2.87 dq (17.1, 7.5) 
-..) 
2.98 dq (17.1, 7.2) 2.97 dq (16.5, 7.5) 2.97 dq (17.0, 7.0) 2.87 dq (17.2, 7.6) 2.98 dq (17.3, 7.6) 2.94 dq (17.1, 7.5) 
17 1.10 t (7.2) 1.09 t (7 .5) 1.08 t (7 .0) 1.07 t (7.6) 1.08 t (7 .6) 1.09 t (7 .5) 
18 3.10 dd (13.5, 8.6) 3.29 dd (13.5, 7.5) 2.94 dd (14.0, 9.0) 3.57 dd (14.0, 7.6) 3.42 q (7.6) 3.30-3.55 m 
3.23 dd (13.5, 5.8) 3.39 dd (13.5, 7.0) 3.28 dd (14.0, 5.2) 3.65 dd (14.0, 8.1) 
19 1.80 m l.60m 2.03m 2.92m 1.34 t (7.6) 2.20-2.41 m 
20 1.25 m l.60m 0.97 d (6.8) 2.20-2.41 m 
21 0.95 t (7.2) 0.95 d (6.5) 0.98 d (6.8) 7.18-7.20 m 
22 0.98 d (6.3) 0.96 d (6.5) 7.23-7.38 m 
23 7.23-7.38 m 
24 7.23-7.38 m 
25 7.18-7.20 m 
NH2 5.48 br. s 
-
1
H NMR data represent chemical shift, multiplicity (Jin Hz). 
combination of partial structure A and D gave an integrated partial structure with a 2,3-
dihydro-4-pyridinone ring. The chemical shift of the ketonic carbonyl carbon, C-15 (Oc 
197.6), in partial structure B indicated bonding of the carbonyl carbon, C-15, to the 
olefinic carbon, C-5, on the 2,3-dihydro-4-pyridinone ring. The chemical shifts of the 
methylene carbon (C-18, Oc 61.2) and the methylene protons [18-Ha (refers to the 
methylene proton that resonates in the upper field), oll 3.10; 18-Hb (lower field), 011 3.23] 
indicated a bond between C-18 and the nitrogen atom. This was confirmed by the NOE 
observations. Irradiation of 2-H proton caused NOE enhancement of the signal of one of 
the methylene protons (18-Hb), and irradiation of 6-H proton caused NOE enhancement of 
another methylene proton (18-Ha). Finally, the one remaining hydrogen atom was bonded 
to the oxygen atom on C-3 to give the complete structure of 4a. NOE enhancement of tne 
signal of the methyl protons (14-H3) on irradiation of the methine proton (2-H) suggested 
that the methyl group (C-14) was pseudo-equatorial on the supposition that the 2-H proton 
was pseudo-axial. 
Neovasipyridone B (4b) had the same molecular formula, C21H 35N03 (HRFABMS 
and 13C NMR data), as neovasipyridone A (4a), and their UV spectra were very similar. 
Their 16 13C resonances due to C-2 to C-17 (Table 3.1) were nearly superimposable, 
indicative that 4b has the same structure, except for the N-alkyl group, as 4a. The 1H 
NMR (Table 3.2) and H,H-COSY data indicated the attachment of 3-methylbutyl to the 
nitrogen atom on the 2,3-dihydro-4-pyridinone ring. Neovasipyridone C (4c) had a 
molecular formula of C20H 33N03 (HREIMS and 
13
C NMR data), which is equal to the loss 
of CH2 from 4a and 4b. The 16 
13C resonances due to C-2 to C-17 (Table 3.1) were nearly 
superimposable on those of 4a and 4b. The 1H NMR (Table 3.2) and H,H-COSY data 
indicated that the 2-methylpropyl is an N-alkyl instead of the 2-methylbutyl in 4a or the 3-
methylbutyl in 4b. 
The structures of neovasipyridones D (4d, C24H33N03), E (4e, C18H29N03), and F (4f, 
C20H32N20 4) were detern1ined by the same method as used for 4b and 4c. The EI mass 
spectra of 4d, 4e, and 4f had ion peaks at m/z [M-43r, [M-57r, [M-153r, and 125, 
indicative of neovasipyridones. The 1H NMR (Table 3.2) and H,H-COSY data for 4d and 
4e indicated that the phenylethyl is an N-alkyl in 4cl and that the ethyl in 4e. The 
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carbamoyl group in 4f was confirmed by the IR absorption band at 1671 cm-1 [11] and the 
D20 exchangeable resonance at On 5.48. 
Neovasipyridones A-F (4a-f) have differentN-alkyl groups: 2-methylbutyl in 4a, 3-
methylbutyl in 4b, 2-methylpropyl in 4c, phenylethyl in 4d, ethyl in 4e, and 3-
carbamoylpropyl in 4f. These compounds and neovasinin (1) have the same side chain. 
The stereochemistries of the asymmetric carbons in neovasipyridones A-F (4a-f) have yet 
to be resolved, but the absolute stereochemistries of neovasinin (1) [2], neovasipyrones (2), 
and neovasifuranones (3) suggest that the stereochemistries of C-2, C-3, and C-9 in 
neovasipyridones (4) are (R,S,S). 
Preliminary leaf spot bioassay indicated that neovasipyridones (4) as well as 
neovasipyrones (2) were not phytotoxic to soybean plant, although neovasinin (1) and 
neovasifuranones (3) are phytotoxic. 
Experimental Section 
General procedure. 
NMR spectra were recorded in CDC13 on a JEOL JNM GX-270 or GX-400 FT NMR 
spectrometer. NMR chemical shifts were referenced to CDCh (011 7.26, Oc 77.0). MS 
were obtained with a JEOL DX-300 or AX-505 spectrometer. Glycerol was the matrix 
used for FABMS. In EIMS, the ionization voltage was 70 eV. IR spectra were measured 
with a JASCO FT/IR-7000 spectrometer, and UV spectra with a Shimadzu UV-2200 UV-
vis recording spectrophotometer. Optical rotations were measured with a Horiba SEPA-
200 high sensitive polarimeter. Daisogel IR-60 was the silica gel used for column 
chromatography. Preparative TLC was performed on a Merck Kieselgel 60 HF254 glass 
plate (20 x 20 x 0.05 cm). 
Fungal material. 
Strain NHL2298 of Neocosmospora vasinfecta E. F. Smith var. africana (von Arx) 
Cannon et Hawksworth used in this study was a gift from Dr. Shun-ichi Udagawa 
(National Institute of Hygienic Sciences, Tokyo) in 1983 and was maintained on potato 
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dextrose agar. 
Fermentation and extraction. 
The fungus was grown in a 500-mL conical flask containing liquid medium (200 mL 
x 200) composed of sucrose (50 g/L), peptone (3 g/L), the extract from 100 g/L on malt, L-
methionine (0.3 g/L), and water, without shaking at 24°C for 21 days in the dark. The 
mycelial mats obtained after filtering the culture broth were rinsed with H20 and dried 
under a hood. The dried mats (620 g) were soaked in Me2CO overnight, after which the 
Me2CO extract was obtained by filtration. This treatment was repeated three times. The 
combined Me2CO extracts were evaporated to dryness. The residue was dissolved in 1 M 
NaHC03 (500 mL) and treated with EtOAc (500 mL). The EtOAc solution obtained was 
placed over Na2S04 and evaporated to dryness. The residue was partitioned with 90% aq. 
MeOH (250 mL) and n-hexane (250 mL). The n-hexane layer obtained was extracted 
with 90% aq. MeOH (2 x 250 mL). The combined MeOH solution was evaporated to 
dryness. 
Isolation of neovasipyridones A-F (4a-f). 
The residue (13.5 g) from MeOH solution was subjected to silica gel column 
chromatography (340 g, 4.6 i.d. x 32 cm). The column was developed successively with 
2000 mL (5 x 400 mL) each of 0, 2, 5, 10, 20, 30, 40, and 50% Me2CO in n-hexane. 
Fraction 1 (455 mg), eluted with 10% Me2CO in n-hexane, was purified by Sephadex LH-
20 column chromatography (2.7 i.d. x 80 cm) with MeOH as the solvent. Each 7 mL of 
eluate constituted one fraction, and fractions 41-44 were combined and evaporated to 
dryness. The residue (30 mg) further was purified by preparative TLC [Me2CO-CHC13 (1 
: 19)] to afford neovasipyridone A (4a, 15.5 mg). Fractions 2 and 3, eluted with 10% 
Me2CO in n-hexane, were combined and evaporated to dryness. The residue (1.29 g) was 
subjected to Sephadex LH-20 column chromatography (3.2 i.d. x 122 cm) with MeOH as 
the solvent. Each 10 mL of eluate constituted one fraction, and fractions 56-61 were 
combined and evaporated to dryness. The residue (73 mg) contained neovasipyridones A 
(4a), B (4b), and C (4c). Removal of 4a from the mixture was achieved by preparative 
40 
TLC [Et0Ac-C6l-L; (7 : 93), quadruple development], giving 4a (6.7 mg) as a constituent 
of a higher R1 band on TLC. The lower R1 band contained 4b and 4c. Compound 4b was 
separated from 4c by repeated HPLC [DAISOPAK SP-120-5-0DS-A (10 i.d. x 250 mm), 
90% aq. MeOH, 1.0 mL/min], giving 4b (14.0 mg, R1 28.0 min) and 4c (11.1 mg, R1 33.0 
min). Fraction 4 (349 mg), eluted with 10% Me2CO in n-hexane, was purified on a 
Sephadex LH-20 column chromatography (2.7 i.d. x 80 cm) with MeOH as the solvent. 
Each 7 mL of eluate constituted one fraction, and fractions 44-47 were combined and 
evaporated to dryness. The residue (168 mg) was purified by preparative TLC 
[Me2CO-CHC13 (1 : 9)], giving neovasipyridone D (4d, 13.8 mg). Fraction 5 (203 mg), 
eluted with 10% Me2CO in n-hexane, was purified on a silica gel column chromatography 
(30 g, 2.2 i.d. x 20 cm) with Me2CO-CHC13 (1 : 9) as the solvent. Each 10 mL of elua{e 
constituted one fraction, and fractions 7 and 8 were combined and evaporated to dryness. 
The residue (13 mg) contained neovasipyridones D (4d) and E (4e), which were separated 
by preparative TLC [Me2CO-CHC13 (1 : 9)], giving 4d (7.9 mg, higher R1 band) and 4e 
(4.9 mg, lower R1 band). Fractions 4 and 5, eluted with 40% Me2CO in n-hexane, and 
fraction 1, eluted with 50% Me2CO inn-hexane, were combined (195 mg) and subjected to 
column chromatography on Sephadex LH-20 (2.3 i.d. x 100 cm) with MeOH as the 
solvent. Each 6 mL of eluate constituted one fraction, and fractions 42-47 were combined 
and evaporated to dryness. The residue (23 mg) was purified by preparative TLC 
[Me2CO-CHC13 (3 : 7)], giving neovasipyridone F (4f, 2.7 mg). 
Neovasipyridone A (4a). 
Oil. [cx]0
20 +366° (c 1.0, EtOH). UV (EtOH) Amax nm (log E): 202 (3.79), 262 
(4.10), 322 (4.14). IR (film) vmax cm-1: 3398, 2964, 2930, 2874, 2858, 1647, 1580, 1462, 
1375, 1350, 1315, 1267, 1241, 1172, 1114. 1H and 
13
C NMR spectral data: Tables 3.1 and 
3.2. FABMS m/z (rel. int.): 350 [M+Hf (100), 332 (10), 306 (14), 236 (30), 196 (12); 
exact mass calcd for C21H36N03 350.2695, found 350.2655. 
Neovasipyridone B (4b). 
Oil. [cx] 0
20 +392° (c 1.0, EtOH). UV (EtOH) Amax nm (log E): 200 (3.71), 263 
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(4.15), 322 (4.19). IR (film) Vmax cm-1: 3362, 2960, 2874, 1638, 1574, 1460, 1392, 1377, 
1334, 1292, 1257, 1201, 1156, 1116, 1083, 1029. 1H and 13C NMR spectral data: Tables 
3.1 and 3.2. FABMS m/z (rel. int.): 350 [M+Hf (100), 306 (15), 196 (10), 154 (39), 149 
(27), 136 (33), 107 (15); exact mass calcd for C21 H36N03 350.2695, found 350.2666. 
Neovasipyridone C (4c). 
Oil. [a]n20 +383° (c 1.0, EtOH). UV (EtOH) Amax nm (log E): 203 (3.98), 262 
(4.11), 323 (4.14). IR (film) Vmax cm-1: 3406, 2967, 2926, 2874, 1639, 1579, 1460, 1369, 
1315, 1261, 1157, 1113. 1H and 13C NMR spectral data: Tables 3.1 and 3.2. EIMS m/z 
(rel. int.): 335 [Mr (55), 292 (100), 278 (23), 222 (15), 182 (41), 125 (19); exact mass 
calcd for C20H 33N03 335.2461, found 335.2488. 
Neovasipyridone D (4d). 
Oil. [a]n20 + 188° (c 1.0, EtOH). UV (EtOH) Amax nm (log E): 202 (3.91), 262 
(3.88), 323 (3.93). IR (film) Vmax cm-1: 3434, 2966, 2928, 2876, 1638, 1576, 1458, 1375, 
1350, 1309, 1261, 1151, 1116. 1H and 13C NMR spectral data: Tables 3.1 and 3.2. EIMS 
m/z (rel. int.): 383 [Mr (34), 340 (100), 326 (20), 267 (26), 230 (36), 212 (20), 162 (26), 
125 (16), 105 (22); exact mass calcd for C24H33N03 383.2460, found 383.2436. 
Neovasipyridone E (4e). 
Oil. [a]n20 + 178° (c 0.5, EtOH). UV (EtOH) Amax nm (log E): 201 (3.82), 262 
(3.72), 322 (3.70). IR (film) Vmax cm-1: 3416, 2966, 2930, 1638, 1580, 1462, 1352, 1311, 
1265, 1151, 1118. 1H and 13C NMR spectral data: Tables 3.1 and 3.2. EIMS m/z (rel. 
int.): 307 [Mr (50), 278 (16), 264 (100), 250 (18), 154 (89), 125 (40); exact mass calcd for 
C18H29N03 307.2148, found 307.2157. 
Neovasipyriclone F (4f). 
Oil. [a]n20 +260° (c 0.2, EtOH). UV (EtOH) Amax nm (log E): 202 (3.61), 262 
(3.91), 322 (3.90). IR (film) vmax cm-1: 3326, 2964, 2930, 2860, 1671, 1638, 1576, 1460, 
1375, 1309, 1263, 1151, 1116. 1H NMR spectral data: Table 3.2. EIMS m/z (rel. int.): 
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-364 [Mt (28), 335 (17), 321 (100), 307 (12), 248 (10), 211 (88), 154 (17), 125 (45); exact 
mass calcd for C20H32N20 4 364.2362, found 364.2352. 
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CHAPTER4 
Incorporation of 13C- and 2H-Labeled Precursors into Neovasinin, 
Neovasipyrones, and Neovasifuranones and the Conversion of 
Neovasifuranone A Aldehyde to Neovasifuranone A 
Introduction 
Neovasinin (1), produced by Neocosmospora vasinfecta NHL2298, has a unique 
bicyclic unit, 2H,5H-pyrano[4,3-b]pyran-2-one [1, 2]. The fungus simultaneously 
produces metabolites biogenetically related to neovasinin (1): neovasinone (11) [3J, 
neovasipyrones (2), neovasifuranones (3), vasinfectins (10), and neovasipyridones (5). 
These metabolites have the following structural features: The carbon skeletons and 
stereochemistries of asymmetric carbons (C-6 and C-10) in neovasipyrones (2) are 
identical to those in neovasinin (1). Neovasipyrones (2), neovasifuranones (3), and 
vasinfectins (10) have the same side chain. Except for N-alkyl groups, C16 carbon 
networks of the neovasipyridones (5) are in agreement with the networks of 
neovasifuranones (3). Moreover, the variety of N-alkyl groups suggests that a Schiff base 
would be formed with alkyl amines and an aldehyde group in the biosynthetic pathway of 
the neovasipyridones (5) [ 4, 5]. These features strongly suggest that neovasinin (1), 
neovasipyrones (2), neovasifuranones (3), and neovasipyridones (5) have the same origin, 
probably biosynthesis from a hexaketide plus five C1 units, the common intermediate being 
an aldehyde compound. To explore this hypothesis, I did incorporation experiments using 
13C-labeled acetates and 13CHT and 13C2Hrlabeled methionine. I also did replacement 
culture and enzymatic conversion of the probable aldehyde compound. The incorporation 
patterns of labeled precursors into neovasinin (1), neovasipyrones (2), and 
neovasifuranones (3), and the in vivo and in vitro conversion of neovasifuranones A 
aldehyde (4a) to neovasifuranone A (3a) are described in this chapter. 
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Preliminary feeding experiments done to clarify the biosynthetic origin of neovasinin 
(1) from this fungus grown on malt extract medium supplemented with peptone and 
methionine [6] were unsuccessful because of the low incorporation of 13C-labeled acetate 
into 1. This probably was caused by dilution of the fed labeled acetate with the 
endogenous unlabeled acetate of the fungus. To solve this problem, various media and 
carbon sources were tested. As a result, incorporation experiments with 13C-labeled 
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Fig. 4.1. 13C NMR spectrum (67.8 MHz) of neovasinin (1) enriched with sodium [1,2-13C2]acetate in DMSO-d6• 
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acetates were done with glycerol-based malt medium to control the carbon economy of the 
cell [7, 8]. In contrast to the studies with labeled acetates, incorporation studies done with 
labeled methionines and conventional malt-peptone-sucrose medium were successful. 
The timing for the supply of precursor to this fungus was determined from growth curves 
obtained by detecting metabolites after various growth periods (data not shown). 
The 13C NMR spectrum of neovasinin (1) enriched with sodium [1,2-13C2Jacetate is 
shown in Fig. 4.1. Results of the feeding expe1iments with 13C-labeled precursors are 
given in Table 4.1 and Fig. 4.2. In the 13C NMR spectrum of 1 derived from sodium [1,2-
13C2]acetate, the signals for C-1 to C-12 were flanked by doublets due to 13C-13C coupling 
[9]. The coupling constants could be unambiguously paired, indicative of the existence of 
six intact acetate units. Six carbons (C-1, C-3, C-5, C-7, C-9, and C-11) were enriched by 
sodium [l-13C]acetate, and the other six carbons (C-2, C-4, C-6, C-8, C-10, and C-12) were 
enriched by sodium [2-13C]acetate. The incorporation of [S-13CH3]-L-methionine indicated 
that the remaining five carbons (C-13 to C-17) were derived from the C1 unit. These 
results show that neovasinin (1) is biosynthesized from a linear hexaketide chain and five 
C1 units. 
In the incorporation experiments with the labeled acetates, neither neovasipyrones A 
II • CH3-C02Na 
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Fig. 4.2. Incorporation patterns of labeled precursors into neovasinin (1), 
neovasipyrones (2), and neovasifuranones (3). 
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CH3 
-Table 4.1. 13C NMR data (67.8 MHz) for neovasinin (1) 
enriched with labeled precursors in DMSO-d6• 
-
relative enrichment 
carbon oc J cc (Hz) [ l- 13C]acetate [2-13C]acetate [1 3CH3]methionine a-shift 
1 164.3 76.3 2.25 0.99 0.78 
2 98.9 76.3 0.83 1.74 1.00* 
3 161.8 60.6 2.65 1.36 0.91 
4 107.6 60.2 0.92 2.25 1.01 
5 155.7 53.3 1.78 1.18 0.99 
6 68.2 53.8 0.82 2.21 1.05 
7 87.7 50.4 2.05 0.97 1.57 
8 131.1 50.4 0.81 2.02 0.98 
9 136.2 43.0 2.00 0.94 1.18 
10 33.2 43.0 1.05 2.64 0.96 
11 29.9 35.2 2.12 0.91 1.26 
12 11.9 35.2 1.02 2.22 1.12 
13 9.1 1.23 1.23 19.36 
14 61.7 1.00* 1.00* 17.95 0.30 
15 20.6 1.02 1.06 23.41 
16 13.3 0.97 1.30 16.08 
17 20.5 1.11 1.20 23.70 
* Enrichments were normalized to these signals. 
(2a) and B (2b) nor neovasifuranones A (3a) and B (3b) were detected in the culture 
filtrate. In the incorporation study done with 13C-labeled methionine, however, these 
metabolites were obtained. In the 13C NMR spectra of the neovasipyrones (2) and 
neovasifuranones (3) enriched with 13C-labeled methionine, five of the signals had 
enhanced intensities greater than the natural abundance (Tables 4.2 and 4.3). The labeling 
patterns of neovasinin (1), neovasipyrones (2), and neovasifuranones (3) with C1 units 
(Fig. 4.2) suggested that 2 and 3 are derived from a hexaketide plus five C1 units, the same 
biosynthetic origin as 1, and that 3 lose one carbon from the hexaketide chain. 
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Table 4.2. 13C NMR data (67.8 MHz) for neovasipyrones A (2a) and B (2b) 
enriched with labeled methionine in acetone-d6• 
2a 2b 
carbon oc rel. enrichment a-shift oc rel. enrichment a-shift 
1 164.9 1.25 164.7 0.69 
2 100.6 1.00* 100.7 1.00* 
3 167.7 1.48 167.5 1.46 
4 110.4 1.28 110.7 0.85 
5 163.5 2.70 163.3 1.42 
6 75.5 1.51 75.2 1.29 
7 132.7 2.02 134.7 1.21 
8 140.3 2.12 140.0 1.16 
9 80.8 1.77 83.2 2.17 
10 38.9 2.52 38.9 1.30 
11 27.6 1.38 26.l 1.05 
12 12.4 1.43 11.9 1.13 
13 9.1 35.96 9.1 13.54 
14 58.8 15.11 0.32 58.7 11.94 0.32 
15 28.7 37.33 28.1 10.39 
16 13.8 26.54 12.4 13.19 
17 14.7 23.31 16.4 16.23 
*Enrichments were nom1alized to these signals. 
The methylene carbon, C-14, of neovasinin (1) that is involved in the formation of 
the pyran ring in the bicyclic unit is derived from C1 unit. In general, C-methylation 
occurs by direct nucleophilic displacement on the S-methyl group of S-adenosyl-L-
methionine before release of the completed polyketide from the synthase complex occurs 
[10-13]. To clarify the level of oxidation at C-14in1 and neovasipyrones (2) and atC-13 
in neovasifuranones (3) during their biosyntheses, [S-13C2H3]-L-methionine was used as the 
precursor [14]. To detennine the number of deuterium atoms retained, a-shifted signals in 
the 13C NMR spectra of the derived metabolites were observed [9, 15]. In the 
13
C NMR 
spectrum of 1, deuterium-induced a-isotope shifts occurred for C-13 to C-17 (Fig. 4.3). 
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Table 4.3. 13C NMR data (67.8 MHz) for neovasifuranones A (3a, in CD30D) 
and B (3b, in CDC13) enriched with labeled methionine. 
3a 3b 
carbon oc rel. enrichment a-shift oc rel. enrichment a-shift 
1 194.0 1.42 189.5 1.00 
2 114.1 0.48 111.9 1.31 
3 208.2 1.16 205.6 0.88 
4 91.0 0.42 88.5 0.44 
5 124.4 0.60 123.7 0.80 
6 146.0 0.67 143.5 0.73 
7 82.3 0.78 82.1 0.65 
8 39.5 0.75 37.5 0.67 
9 28.1 0.72 24.4 1.02 
10 12.7 1.00* 11. l 1.00* 
11 24.2 0.42 22.5 1.40 
12 11.6 24.85 10.6 15.64 
13 53.2 16.54 0.30 53.4 14.80 0.32 
14 25.2 14.71 23.9 15.96 
15 14.8 18.86 12.8 11.32 
16 15.2 28.85 15.6 16.58 
* Enrichments were normalized to these signals. 
The intensity of the signals for C-13 to C-17 being lower than that of the expected normal 
signals is consistent with the retention of deuterium atoms at these positions. In particular, 
a triplet (J = 22 Hz) centered 0.30 ppm upfield of the main signal (C-14) is consistent with 
the retention of one deuterium atom (Table 4.1 and Fig. 4.3). In the 13C NMR spectra of 
neovasipyrones A (2a) and B (2b) derived from this precursor, the natural signals of C-14 
showed triplets centered respectively 0.32 and 0.32 ppm upfield of the C-14 signal (Table 
4.2). In the 13C NMR spectra of neovasifuranones A (3a) and B (3b ), the natural signals 
of C-13 also showed respective triplets centered 0.30 and 0.32 ppm upfield of the C-13 
signal (Table 4.3). The multiplicity and overlapping of the a-shifted signals of the other 
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Fig. 4.3. 13C NMR spectrum (67.8 MHz) of neovasinin (1) enriched with [S-13C2H3]methionine in DMSO-d6• 
C1 unit carbons (C-13, C-15, C-16, and C-17 in 1and2; C-12, C-14, C-15, and C-16 in 3) 
hampered further examination, but their carbons mainly seem to retain three deuterium 
atoms; the actual number of deuterium atoms retained at these positions would be 
determined by obtaining simultaneous proton- and deuterium-decoupled 13C NMR spectra 
[9, 15, 16]. These findings indicate that the key intermediate in 1, 2, and 3 is an aldehyde 
rather than a hydroxymethyl compound, and that it is formed by the oxidation of the 
introduced C1 unit, C-14 in 1 and 2 and of C-13 in 3. 
To investigate this possibility, synthesis and isolation of the aldehyde intermediates 
were attempted. Unfortunately, they were unsuccessful for neovasinin (1) and the 
neovasipyrones (2). A small amount of neovasifuranone A aldehyde (4a) and 
neovasifuranone B aldehyde (4b), however, were isolated from the culture filtrate (each 
0.05 mg/L of medium, data not shown). Moreover, neovasifuranone A aldehyde ( 4a) was 
synthesized from neovasifuranone A (3a) by oxidation with manganese dioxide (Mn02) 
[17, 18]. In the replacement culture experiment done with this fungus, compound 4a was 
converted to 3a; but, 3a was not converted to any compound. As expected, neovasinone 
(11) and neovasipyrones A (2a) and B (2b) were not converted to neovasinin (1), nor was 
1 converted to 11. Enzymatic conversion was done with the cytosol fraction from this 
fungus [19, 20]. When this fraction was incubated with 4a in the presence of NADPH, 
only 3a was formed (Fig. 4.4). When, however, this fraction was incubated with 4a in the 
presence of NADH, or in the absence of the coenzyme, 4a was not converted to 3a. No 
reverse reaction (from 3a to 4a) occurred under various conditions (pH, cofactor, etc.). 
These results indicate that the enzyme(s) catalyzes reduction of the aldehyde group in 4a to 
the hydroxymethyl group and specifically requires NADPH as the primary electron donor. 
From the results described above, I propose the biosynthetic pathway shown in 
scheme 1. Neovasinin (1), neovasipyrones (2), neovasifuranones (3), and 
neovasipyridones (5) are derived from a hexaketide chain plus five C1 units. Neovasinin 
(1) and the neovasipyrones (2) are biosynthesized from hypothetical common 
intermediates (6, two diastereomers with respect to the hydroxymethine carbon) that are 
produced by the oxidation of one C1 unit in the hexaketide chain. Compound 1 is formed 
from 6 via neovasipyrone aldehydes (7). The dehydration/cyclization of 6 into 7 and the 
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Fig. 4.4. Enzymatic conversion of neovasifuranone A aldehyde (4a) to neovasifuranone 
A (3a) in the presence of NADPH (A) or in the absence of the coenzyme (B). 
subsequent reduction of 7 give neovasipyrones A (2a) and B (2b). Neovasifuranones (3) 
and neovasipyridones (S) are biosynthesized from hypothetical intermediates (8) that are 
produced by decarboxylation of carboxy group in the intermediates (6). Neovasifuranones 
A (3a) and B (3b) are formed through the dehydration/cyclization of 8 into the 
neovasifuranone aldehydes (4) and the subsequent reduction of 4. Neovasipyridones (S) 
are formed by the Schiff base formation of 8 with alkyl amines which seem to come from 
amino acids (Sa: isoleucine, Sb: leucine, Sc: valine, Sd: phenylalanine, Se: alanine, Sf: 
glutamine) and the subsequent dehydration/cyclization of 9. Neovasinone (11) would be 
biosynthesized by the dehydrogenation of hemiacetal (12) or through oxidation of 
neovasipyrone aldehydes (7) to their carboxylic acids. Vasinfectins (10) could be formed 
from intermediates 6 plus an additional C4 unit or from intermediates 8 plus a C5 unit. 
Metabolites containing the bicyclic unit, as neovasinin (1), have been reported in 
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Fusarium chlamydosporum and F. tricinctum (chlamydosporol, isochlamydosporol, and 0-
methylisochlamydosporol) [21, 22] and in Gelasinospora multiforis (multiforisin C) [23]. 
Multiforisin C, in particular, seems to be an artifact derived from an aldehyde compound 
(multiforisin B) such as neovasipyrone aldehydes (7). An acetal compound such as 
multiforisin C and 0-methylisochlamydosporol also was isolated from N. vasinfecta 
NHL2298 (data not shown), but isolation of its aldehyde was unsuccessful, probably 
owing to unstableness and easy conversion. Although the biosynthesis of chlamydosporol 
and isochlamydosporol have yet to be investigated, they probably are formed via similar 
aldehyde intermediates (7) as in the biosynthesis of neovasinin (1). 
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Experimental Section 
General procedure. 
NMR spectra were recorded on a JEOL JNM GX-270 FT NMR spectrometer. All 
NMR chemical shifts were referenced against the deuterated solvent used (CDCh, OH 7.26, 
Oc 77.0; Me2CO-d6 , Oc 30.3; CD30D, Oc 49.8; DMSO-d6, Oc 39.5). Mass spectrum was 
obtained with a JEOL AX-505 spectrometer. IR spectrum was measured with a JASCO 
FT/IR-7000 spectrometer, and UV spectrum with a Shimadzu UV-vis recording 
spectrophotometer. Optical rotation was determined with a Horiba SEPA-200 high 
sensitive polarimeter. Daisogel IR-60 was the silica gel used for the column? 
chromatography. Preparative TLC was done on a Merck Kieselgel 60 HF254 glass plate 
(20 x 20 x 0.05 cm). 
Fungal material. 
Strain NHL2298 of Neocosmospora vasinfecta E. F. Smith var. africana (von Arx) 
Cannon et Hawksworth used in this study was a gift from Dr. Shun-ichi Udagawa 
(National Institute of Hygienic Sciences, Tokyo) in 1983 and was maintained on potato 
dextrose agar. 
Incorporation of labeled acetates. 
The fungus was grown in a 500-mL conical flask containing liquid medium (100 mL 
x 20) composed of glycerol (10 g/L), peptone (3 g/L), the extract from 50 g/L on malt, and 
water, without shaking at 24°C. Sodium [1,2-13C:Jacetate (99 atom % 13C, 200 mg/day), 
sodium [l-13C]acetate (99 atom % 13C, 200 mg/day), or sodium [2-13C]acetate (99 atom % 
13C, 200 mg/day) and unlabeled L-methionine (100 mg/day) dissolved in sterilized water 
(20 mL) were supplied to 5-day-old culture, every 24 hr from day 5 to day 9. After further 
3 days, the culture filtrate obtained after filtering the culture broth was acidified to pH 2.0 
with HCl and extracted with EtOAc ( 4 x 500 mL). The EtOAc extracts were dried over 
Na2S04, concentrated, and extracted with I M NaHC03 (2 x 0.5 vol.). The NaHC03 
solution was acidified to pH 2.0 with HCl and extracted with EtOAc (4 x 1 vol.) to afford 
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the acidic EtOAc-soluble (AE) fraction. AE fraction was subjected to silica gel partition 
column chromatography (20 g, impregnated with 12 mL of 0.1 M HC02H, 2.1 i.d. x 13 
cm). The column was developed successively with each 100 mL of 10, 20, 30, 40, and 
50% EtOAc in n-hexane saturated with 0.1 M HC02H. The 20 and 30% fractions were 
combined and concentrated. The residue was purified by preparative TLC 
[Me2CO-CHClrAcOH (10: 90 : 1), quadruple development] to afford neovasinin (ca. 14 
mg). 
Incorporation of labeled methionines. 
The fungus was grown in a 500-mL conical flask containing liquid medium (100 mL 
x 10) composed of sucrose (50 g/L), peptone (3 g/L), the extract from 100 g/L on malt, and 
water, without shaking at 24°C. [S-13CH3]-L-methionine (99 atom % 
13C, 100 mg/day) or 
[S-13C2H3]-L-methionine (99 atom % 
13C, 99 atom % 2H, 50 mg/day) dissolved in sterilized 
water (10 mL) was supplied to 8-day-old culture, every 24 hr from day 8 to day 12. After 
further 9 (13C-labeled methionine) or 7 days (13C2H 3-labeled methionine), the culture 
filtrate obtained after filtering the culture broth was acidified to pH 2.0 with HCl and 
extracted with EtOAc (4 x 500 mL). The EtOAc exn·acts were dried over Na2S04, 
concentrated, and washed with 1 M NaHC03 (2 x 0.5 vol.) to afford the neutral EtOAc-
soluble (NE) fraction. The N aHC03 washings were acidified to pH 2.0 with HCl and 
extracted with EtOAc (4 x 1 vol.) to afford the acidic EtOAc-soluble (AE) fraction. AE 
fraction was subjected to silica gel partition column chromatography (20 g, impregnated 
with 12 mL of 0.1 M HC02H, 2.1 i.d. x 13 cm). The column was developed successively 
with each 100 mL of 10, 20, 30, 40, and 50% EtOAc in n-hexane saturated with 0.1 M 
HC02H. The 20 and 30% fractions were combined and concentrated. The residue was 
purified by preparative TLC [Me2CO-CHCh-AcOH (10: 90 : 1), quadruple development] 
to afford neovasinin (13C-labeled methionine: 63 mg, 13C2~-labeled methionine: 91 mg). 
The 40 and 50% fractions were purified by preparative TLC [Me2CO-CHC13-AcOH (25 : 
. 13 13 2 6 75 : 1), quadruple development] to afford neovas1pyrones A ( C: 47 mg, C H3 : 1 mg) 
and B (13C: 18 mg, 13C2H3 : 22 mg). NE fraction was purified by preparative TLC 
[Me2CO-CHC13 (1 : 3), triple development] to afford neovasifuranones A (1
3C: 11 mg, 
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13C2H O 13 13C2 
3 : 1 mg) and B ( C: 6 mg, H3 : 7 mg). 
Neovasifuranone A aldehyde ( 4a). 
A solution of 4a (10 mg) and Mn02 (200 mg) in dry C6H6 (3 mL) was stirred for 8 hr 
at 28°C. The reaction mixture was diluted with water-saturated EtOAc and filtered 
through silica gel (Kieselgel 60 HF254), and the filtrate was concentrated. The residue was 
purified by preparative TLC [Me2CO-n-hexane (3 : 7), double development] to afford 4a 
(2.7 mg) as an oil. [cx]n22 -165° (c 0.1, EtOH). UV (EtOH) Amax nm (log£): 202 (3.90), 
234 (4.05), 271 (4.03). IR (film) Ymax cm-1: 3439, 2965, 1717, 1680, 1570, 1462, 1420, 
1366, 1262, 1047. 1H NMR (270 MHz, CDC13): 8 0.84 (3H, d, J = 6.8 Hz, H-16), 0.91 
(3H, t, J = 7.3 Hz, H-10), 1.14 (lH, m, H-9), 1.28 (3H, t, J = 7.6 Hz, H-12), 1.33 (lH, m, 
H-9), 1.52 (lH, m, H-8), 1.59 (3H, s, H-14), 1.72 (3H, d, J = 1.2 Hz, H-15), 3.03 (lH, dq,J 
= 15.2, 7.6 Hz, H-11), 3.10 (lH, dq, J = 15.2, 7.6 Hz, H-11), 3.82 (lH, br. d, J = 5.8 Hz, 
H-7), 5.53 (lH, dq, J = 1.2, 1.2 Hz, H-5), 9.80 (lH, s, H-13). EIMS m/z (rel. int.): 280 
[Mt (8), 262 (21), 223 (23), 205 (10), 195 (14), 167 (21), 149 (15), 127 (40), 97 (100), 71 
(14), 57 (36). 
Replacement culture. 
The fungus was grown in a test tube (10 i.d. x 75 mm) containing liquid medium (0.5 
mL x 5) composed of sucrose (50 g/L), peptone (3 g/L), malt extract (DIFCO, 20 g/L), and 
water, without shaking at 24°C. After 8 days incubation the medium was replaced with 
0.1 M potassium phosphate buffer (pH 7.0), and the fungus was cultured for 2 days. Then 
the buffer was replaced with fresh phosphate buffer with or without the test materials (10 
µg/test tube), and the fungus was cultured for 4 days. The converted products were 
extracted from the culture filtrate (with or without acidifying) using EtOAc. The products 
were detected by HPLC analysis [COSMOSIL 5C18-AR (4.6 i.d. x 150 mm), 
MeOH-H20-CH3CN-AcOH (50: 40: 10: 0.5), 0.5 mL/min, 270 nm]. 
Preparation of cytosol fraction. 
The fungus was grown in a 500-mL conical flask containing liquid medium (100 mL 
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x 10) composed of sucrose (50 g/L), peptone (3 g/L), the extract from 100 g/L on malt, L-
methionine (0.3 g/L), and water, without shaking at 24°C for 8 days. Subsequent all 
procedures were done at 0 to 5°C, and 50 mM potassium phosphate buffer (pH 7 .0) 
containing 0.5 mM dithiothreitol and 6 µM leupeptin was used as the buffer, unless 
otherwise stated. The mycelial mats obtained after filtering the culture broth were washed 
with water (x 3) and the buffer (x 1). The washed mycelia (69 g, wet weight) were ground 
with sea sand (24 g) and the buffer (140 mL) in a mortar and pestle. The homogenate was 
centrifuged at 800 x g for 10 min and then at 12,000 x g for 15 min to give the cell-free 
extract. The extract was centrifuged at 105,000 x g for 90 min, and the resulting 
supernatant was obtained as the cytosol fraction. The cytosol fraction, to which glycerol 
(final concentration, 25%) was added, was stored at -80°C until use. Protein c.ontent (1.1 
mg/mL) was estimated by a method of Bradford [24] with bovine serum albumin as the 
standard. 
Enzyme assay. 
The reaction mixture (total 50 µL) in a microtube (1.5 mL) consisted of the buffer 
(33 µL), 1.5 mM test material (2 µLin MeOH), 20 mM coenzyme (5 µLin the buffer), and 
the cytosol fraction (10 µL). NADH, NADPH, NAD+, or NADP+ was used as the 
coenzyme. The reaction mixture was incubated at 30°C for 30 min with shaking (100 
rpm), and the products were extracted with water-saturated EtOAc (100 µL x 3). The 
reaction products were detected by HPLC analysis [COSMOSIL 5C18-AR (4.6 i.d. x 150 
mm), MeOH-H20-CH3CN-AcOH (50: 40: 10: 0.5), 0.5 mL/min, 270 nm]. 
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CHAPTER 5 
Conclusion 
Neocosmospora vasinfecta E. F. Smith is a pathogen which causes root- and fruit-rot 
and seedling damping-off in the Malvaceae, Leguminosae, Piperaceae, Cucurbitaceae, etc., 
species that include pepper, groundnuts, soybean, beans, coconuts, Albizzia, Crotalaria 
spp. Neovasinin has been isolated from the culture filtrate of a strain (NHL2298) of this 
fungus and is a new type of fungal metabolite with a unique bicyclic unit, 2H,5H-
pyrano[4,3-b]pyran-2-one. The purpose of this study was to determine the biosynthetic 
pathway of neovasinin, in particular the bicyclic unit formation mechanism. 
First, the isolation of metabolites biogenetically related to neovasinin was attempted. 
Neovasipyrones A and B, neovasifuranones A and B, and vasinfectins A and B were 
isolated from the culture filtrate of this fungus. Their structures were clarified by 
spectroscopic methods, X-ray analysis, and chemical reactions. The neovasipyrones and 
neovasinin have the same carbon skeleton. Neovasipyrones, neovasifuranones, and 
vasinfectins have the same side chain with the same stereochemistry of asymmetric 
carbons. The stereochemistries of the asymmetric carbons in these metabolites are 
consistent with the stereochemistry of neovasinin. These findings suggest that neovasinin 
and these isolated metabolites are biosynthesized from a common intermediate. 
Neovasipyridones A-F were isolated from mycelial mats of N. vasinfecta NHL2298, and 
their structures were determined by spectroscopic methods. The neovasipyridones and 
neovasinin have the same side the neovasipyridones each having a different N-alkyl 
group. These findings suggest that neovasinin and these metabolites are formed from a 
common intermediate; an aldehyde. 
To confirm the polyketide origin of neovasinin, incorporation experiments with 13C-
labeled acetate and 13C-labeled methionine of neovasinin next were done. The findings 
indicate that neovasinin is biosynthesized from a linear hexaketide plus five C1 units. The 
data from the incorporation experiments done with the 13C-labeled methionine of the 
neovasipyrones and neovasifuranones suggest that they also are derived from a linear 
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hexaketide plus five C1 units and that in the case of neovasifuranones the hexaketide is 
subject to further decarboxylation. 
Finally, incorporation experiment using [S-13C2H3]-L-methionine of neovasinin, 
neovasipyrones, and neovasifuranones was done to examine the oxidation level of the 
intermediate. The C1 unit carbons of these metabolites that correspond to the C-14 in 
neovasinin retained only one deuterium atom through the biosynthetic pathway. These 
findings suggest that the common intermediate of these metabolites is an aldehyde. 
This possibility was examined using the replacement culture method and enzymatic 
conversion. In those experiments, the neovasifuranone A aldehyde specifically was 
converted to neovasifuranone A, but the reverse reaction did not occur. These results are 
a strong indication of the existence of a common aldehyde intermediate. The intermediate 
that is converted directly to neovasinin, however, has yet to be obtained. 
Investigations that require for a deeper understanding of neovasinin biosynthesis are 
(i) Determination of the stereochemistries of all the asymmetric carbons in the 
neovasifuranones and neovasipyridones. 
(ii) Obtaining the hypothetical intermediates, such as the neovasifuranone A aldehyde, by 
synthesis, isolation, and enzyme inhibition. 
(iii) Conversion of the hypothetical intermediates in vivo and in vitro. 
The studies reported here contribute to our understanding of the biosynthesis of 
neovasinin-related metabolites and various secondary metabolites. Furthermore, N. 
vasinfecta can be used to study the regulation of secondary metabolism as related to 
pathogenesis. 
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Summary 
Neocosmospora vasinfecta E. F. Smith is a pathogen which causes root- and fruit-rot 
and seedling damping-off in the Malvaceae, Leguminosae, Piperaceae, Cucurbitaceae, etc. 
Neovasinin has been isolated from a strain (NHL2298) of N. vasinfecta and is phytotoxic to 
soybean, a host plant of this fungus. Its structure have been deduced by spectroscopic 
methods, X-ray analysis, and degradation reaction. Neovasinin has a unique bicyclic unit, 
2H,5H-pyrano[4,3-b]pyran-2-one and probably is biosynthesized from a hexaketide plus 
five C1 units. The purpose of this study was to determine the biosynthetic pathway of 
neovasinin, in particular the bicyclic unit frnmation mechanism. 
First, the isolation of metabolites biogenetically related to neovasinin was attempted. 
Neovasipyrones A and B, neovasifuranones A and B, and vasinfectins A and B were 
isolated from the culture filtrate of this fungus. Their structures were clarified by 
spectroscopic methods. The stereochemistry of the neovasipyrones were determined by X-
ray analysis and oxidation and degradation reaction. This results indicated that 
neovasipyrones are diastereomer of each other. The stereochemistries of neovasifuranones 
and vasinfectins were determined by oxidation and degradation reaction, and these 
compounds also were diastereomer of each other. 
Neovasipyridones A-F were isolated from the mycelial mats of this fungus. Their 
structures were determined by spectroscopic methods. Neovasipyridones have each 
different N-alkyl group. 
Neovasinin and neovasipyrones have the same carbon skeleton, and the 
stereochemistries of asymmetric carbons in neovasipyrones are consistent with the 
stereochemistry of neovasinin. Neovasipyrones and neovasifuranones have different ring 
system, but they have the same side chain. Except for the N-alkyl groupsC16 carbon 
networks of neovasipyridones is agreement with the networks of neovasifuranones. 
Moreover, the variety of N -alkyl groups suggests that a Schiff base would be formed with 
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alkyl amines and an aldehyde group in the biosynthetic pathway of the neovasipyridones. 
These features suggest that these metabolites have the same biosynthetic origin, probably 
biosynthesis from the common aldehyde intermediate. To explore this hypothesis, 
incorporation experiments with isotope-labeled acetate and methionine were done. The 
incorporation pattern of labeled precursors into neovasinin indicated that neovasinin is 
biosynthesized from a linear hexaketide plus five cl units. In the incorporation experiments 
of neovasipyrones and neovasifuranones with 13C-labeled methionine, five of C1 unit were 
introduced. The labeling patterns of these metabolites suggested that neovasipyrones and 
neovasifuranones are derived from a hexaketide and that neovasifuranones lose one carbon 
from the hexaketide chain. In the incorporation experiment of neovasinin with 13C2H3-
labeled methionine, the C1 unit carbon, C-14, in neovasinin retained only one deuterium 
atom. The same results were observed with neovasipyrones and neovasifuranones. These 
findings indicate that the Cl unit carbons are oxidized to aldehyde in the step of 
biosynthesis. This possibility was examined using the replacement culture method and 
enzymatic conversion. In these experiments, neovasifuranone A aldehyde specifically was 
converted to neovasifuranone A, but the reverse reaction did not occur. These results are a 
strong indication of the existence of a common aldehyde inte1mediate. 
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